Background	Background	NN	0
A	A	DT	0
plethora	plethora	NN	0
of	of	IN	0
circumstantial	circumstantial	JJ	B-NP
evidence	evidence	NN	I-NP
implicates	implicates	NN	0
cyclin-dependent	cyclin-dependent	JJ	B-NP
kinase	kinase	NNS	I-NP
downregulation	downregulation	NN	I-NP
(	(	-LRB-	0
cyclin	cyclin	NN	B-NP
dependent	dependent	JJ	I-NP
kinase	kinase	NN	I-NP
)	)	-RRB-	0
inhibitor	inhibitor	JJ	B-NP
p27	p27	NN	I-NP
in	in	IN	0
prostate	prostate	JJ	B-NP
cancer	cancer	NN	I-NP
.	.	.	0
While	While	IN	0
greater	greater	JJR	0
than	than	IN	0
85	85	CD	0
%	%	NN	0
of	of	IN	0
terminally	terminally	JJ	0
differentiated	differentiated	JJ	0
secretory	secretory	JJ	B-NP
cell	cell	NN	I-NP
in	in	IN	0
normal	normal	JJ	B-NP
human	human	JJ	I-NP
prostate	prostate	NN	I-NP
display	display	VBP	0
strong	strong	JJ	0
nuclear	nuclear	JJ	0
staining	staining	NN	0
for	for	IN	0
p27	p27	NNP	B-NP
,	,	,	0
all	all	DT	0
cases	cases	NNS	0
of	of	IN	0
high-grade	high-grade	JJ	0
prostatic	prostatic	JJ	B-NP
intraepithelial	intraepithelial	JJ	I-NP
neoplasia	neoplasia	NN	I-NP
,	,	,	0
invasive	invasive	JJ	B-NP
carcinoma	carcinoma	NN	I-NP
,	,	,	0
and	and	CC	0
pelvic	pelvic	JJ	B-NP
lymph	lymph	NN	I-NP
node	node	NN	I-NP
metastases	metastases	VBP	0
studied	studied	VBN	0
by	by	IN	0
DeMarzo	DeMarzo	NNP	B-NP
et	et	NNP	0
al.	al.	NNP	0
p27	p27	NNP	B-NP
showed	showed	VBD	I-NP
down-regulation	down-regulation	JJ	I-NP
[	[	-LRB-	0
1	1	LS	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
low	low	JJ	0
p27	p27	CD	B-NP
expression	expression	NN	I-NP
correlates	correlates	NN	0
with	with	IN	0
higher	higher	JJR	0
mean	mean	JJ	0
gleason	gleason	NNP	B-NP
score	score	NN	I-NP
,	,	,	0
a	a	DT	0
number	number	NN	0
of	of	IN	0
prognostic	prognostic	JJ	B-NP
morphological	morphological	JJ	I-NP
feature	feature	NN	I-NP
,	,	,	0
and	and	CC	0
decreased	decreased	JJ	0
survival	survival	NN	0
[	[	-LRB-	0
2	2	CD	0
3	3	CD	0
4	4	CD	0
]	]	-RRB-	0
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
p27	p27	NNP	B-NP
may	may	MD	0
be	be	VB	0
a	a	DT	0
prostate	prostate	JJ	B-NP
tumor	tumor	NN	I-NP
suppressor	suppressor	NN	I-NP
.	.	.	0
In	In	IN	0
support	support	NN	0
of	of	IN	0
this	this	DT	0
notion	notion	NN	0
,	,	,	0
the	the	DT	0
p27	p27	JJ	B-NP
protein	protein	NN	I-NP
has	has	VBZ	0
been	been	VBN	0
identified	identified	VBN	0
as	as	IN	0
a	a	DT	0
target	target	NN	0
of	of	IN	0
viral	viral	JJ	B-NP
oncoprotein	oncoprotein	NN	I-NP
[	[	-LRB-	0
5	5	CD	0
6	6	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
unlike	unlike	IN	0
traditional	traditional	JJ	0
tumor	tumor	NN	B-NP
suppressor	suppressor	NN	I-NP
,	,	,	0
the	the	DT	0
p27	p27	JJ	B-NP
gene	gene	NN	I-NP
rarely	rarely	RB	0
shows	shows	VBZ	0
homozygous	homozygous	JJ	B-NP
inactivation	inactivation	NN	I-NP
in	in	IN	0
cancer	cancer	NN	B-NP
cell	cell	NN	I-NP
[	[	-LRB-	0
7	7	CD	0
8	8	CD	0
9	9	CD	0
]	]	-RRB-	0
,	,	,	0
a	a	DT	0
finding	finding	NN	0
that	that	IN	0
points	points	NNS	0
towards	towards	IN	0
alternative	alternative	JJ	0
mechanisms	mechanisms	NNS	0
of	of	IN	0
p27	p27	NN	B-NP
inactivation.	inactivation.	NN	I-NP
p27	p27	NN	B-NP
specifically	specifically	FW	0
inhibits	inhibits	FW	0
cdk	cdk	NN	B-NP
,	,	,	0
which	which	WDT	0
mediate	mediate	JJ	0
entry	entry	NN	0
into	into	IN	0
S	S	NNP	B-NP
phase	phase	NN	I-NP
[	[	-LRB-	0
10	10	CD	0
11	11	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
level	level	NN	0
of	of	IN	0
p27	p27	NNP	B-NP
is	is	VBZ	0
higher	higher	JJR	0
in	in	IN	0
quiescent	quiescent	NN	0
than	than	IN	0
in	in	IN	0
proliferating	proliferating	VBG	B-NP
cell	cell	NN	I-NP
,	,	,	0
and	and	CC	0
this	this	DT	0
increase	increase	NN	0
in	in	IN	0
p27	p27	CD	B-NP
abundance	abundance	NN	I-NP
is	is	VBZ	0
required	required	VBN	0
for	for	IN	0
an	an	DT	0
effective	effective	JJ	0
cell	cell	NN	B-NP
cycle	cycle	NN	I-NP
exit	exit	NN	I-NP
[	[	-LRB-	0
12	12	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
cell	cell	NN	B-NP
cycle-dependent	cycle-dependent	JJ	I-NP
variation	variation	NN	I-NP
in	in	IN	0
p27	p27	CD	B-NP
level	level	JJ	I-NP
are	are	VBP	0
not	not	RB	0
reflected	reflected	VBN	0
by	by	IN	0
similar	similar	JJ	0
changes	changes	NNS	0
in	in	IN	0
p27	p27	NNP	B-NP
mRNA	mRNA	NNP	I-NP
[	[	-LRB-	0
13	13	CD	0
]	]	-RRB-	0
.	.	.	0
Many	Many	JJ	0
aggressive	aggressive	JJ	B-NP
prostate	prostate	NN	I-NP
cancer	cancer	NN	I-NP
display	display	VBP	0
decreased	decreased	VBN	B-NP
p27	p27	CD	I-NP
protein	protein	NN	I-NP
level	level	JJ	I-NP
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
high	high	JJ	0
p27	p27	NNP	B-NP
mRNA	mRNA	NNP	I-NP
[	[	-LRB-	0
14	14	CD	0
]	]	-RRB-	0
,	,	,	0
suggesting	suggesting	VBG	0
that	that	IN	0
p27	p27	CD	B-NP
depletion	depletion	NN	I-NP
may	may	MD	0
result	result	VB	0
from	from	IN	0
ectopic	ectopic	JJ	B-NP
proteolysi	proteolysi	NN	I-NP
.	.	.	0
In	In	IN	0
fact	fact	NN	0
,	,	,	0
p27	p27	CD	B-NP
depletion	depletion	NN	I-NP
in	in	IN	0
several	several	JJ	0
cancers	cancers	NNS	0
was	was	VBD	0
shown	shown	VBN	0
to	to	TO	0
result	result	VB	0
from	from	IN	0
increased	increased	JJ	0
proteolysi	proteolysi	NN	B-NP
via	via	IN	0
the	the	DT	0
ubiquitin	ubiquitin	JJ	B-NP
/	/	CD	I-NP
proteasome	proteasome	JJ	I-NP
system	system	NN	I-NP
[	[	-LRB-	0
15	15	CD	0
16	16	CD	0
17	17	CD	0
18	18	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
system	system	NN	0
employs	employs	VBZ	0
a	a	DT	0
cascade	cascade	NN	0
of	of	IN	0
enzymatic	enzymatic	JJ	B-NP
reaction	reaction	NN	I-NP
that	that	IN	0
covalently	covalently	NNS	0
attach	attach	VBP	0
a	a	DT	0
ubiquitin	ubiquitin	JJ	B-NP
chain	chain	NN	I-NP
to	to	TO	0
substrate	substrate	VB	0
proteins	proteins	NNS	0
,	,	,	0
thereby	thereby	RB	0
targeting	targeting	VBG	0
them	them	PRP	0
to	to	TO	0
the	the	DT	0
proteasome	proteasome	NN	B-NP
[	[	-LRB-	0
19	19	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
ubiquitin	ubiquitin	JJ	B-NP
transfer	transfer	NN	I-NP
reaction	reaction	NN	I-NP
involves	involves	VBZ	0
three	three	CD	0
enzymes	enzymes	NNS	0
:	:	:	0
E1	E1	CD	0
,	,	,	0
which	which	WDT	0
mediates	mediates	VBZ	0
the	the	DT	0
ubiquitin	ubiquitin	NN	B-NP
atp-dependent	atp-dependent	NN	I-NP
activation	activation	NN	I-NP
,	,	,	0
and	and	CC	0
E2	E2	NNP	0
,	,	,	0
or	or	CC	0
conjugating	conjugating	VBG	B-NP
enzyme	enzyme	NN	I-NP
ubiquitin	ubiquitin	NN	I-NP
(	(	-LRB-	0
ubiquitin	ubiquitin	NN	B-NP
conjugating	conjugating	VBG	I-NP
)	)	-RRB-	0
,	,	,	0
which	which	WDT	0
,	,	,	0
together	together	RB	0
with	with	IN	0
an	an	DT	0
E3	E3	NN	B-NP
ubiquitin	ubiquitin	NN	I-NP
ligase	ligase	NN	I-NP
,	,	,	0
transfers	transfers	VBZ	0
ubiquitin	ubiquitin	VBN	0
to	to	TO	0
the	the	DT	0
target	target	NN	B-NP
protein	protein	NN	I-NP
.	.	.	0
biochemical	biochemical	JJ	B-NP
study	study	NN	I-NP
identified	identified	VBD	0
SCF	SCF	NNP	B-NP
SKP2	SKP2	NNP	0
,	,	,	0
an	an	DT	0
E3	E3	NN	0
that	that	IN	0
mediates	mediates	FW	0
p27	p27	NN	B-NP
ubiquitylation	ubiquitylation	NN	I-NP
in	in	FW	0
vitro	vitro	NNP	B-NP
[	[	-LRB-	0
20	20	CD	0
21	21	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
complex	complex	NN	0
consists	consists	VBZ	0
of	of	IN	0
at	at	IN	0
least	least	JJS	0
four	four	CD	0
proteins	proteins	NNS	0
:	:	:	0
SKP1	SKP1	CD	B-NP
,	,	,	0
cullin	cullin	NNP	B-NP
1	1	NN	I-NP
,	,	,	0
HRT1	HRT1	NNP	B-NP
(	(	-LRB-	0
=RBX1	=RBX1	CD	0
/	/	CD	0
ROC1	ROC1	CD	B-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
SKP2	SKP2	NNP	B-NP
.	.	.	0
SKP2	SKP2	NNP	B-NP
contains	contains	VBZ	0
a	a	DT	0
so-called	so-called	JJ	0
F-box	F-box	NN	B-NP
,	,	,	0
which	which	WDT	0
mediates	mediates	VBP	0
binding	binding	VBG	0
to	to	TO	0
SKP1	SKP1	CD	B-NP
,	,	,	0
and	and	CC	0
c-terminal	c-terminal	NN	B-NP
leucine-rich	leucine-rich	JJ	I-NP
repeat	repeat	NN	I-NP
that	that	WDT	0
recognize	recognize	VBP	0
p27	p27	CD	B-NP
.	.	.	0
cullin	cullin	NNP	B-NP
1	1	NN	I-NP
,	,	,	0
in	in	IN	0
turn	turn	NN	B-NP
bind	bind	NN	I-NP
to	to	TO	0
SKP1	SKP1	CD	B-NP
,	,	,	0
and	and	CC	0
together	together	RB	0
with	with	IN	0
HRT1	HRT1	NNP	B-NP
,	,	,	0
mediates	mediates	VBG	0
the	the	DT	0
interaction	interaction	NN	0
with	with	IN	0
the	the	DT	0
ubiquitin-conjugating	ubiquitin-conjugating	JJ	B-NP
enzyme	enzyme	NN	I-NP
CDC34	CDC34	CD	I-NP
/	/	CD	0
UBC3	UBC3	CD	B-NP
.	.	.	0
CKS1	CKS1	NNP	B-NP
,	,	,	0
a	a	DT	0
small	small	JJ	0
protein	protein	NN	B-NP
that	that	IN	0
associates	associates	NNS	0
with	with	IN	0
CDKs	CDKs	JJ	0
and	and	CC	0
greatly	greatly	RB	0
stimulates	stimulates	CD	0
p27	p27	CD	B-NP
ubiquitylation	ubiquitylation	NN	I-NP
,	,	,	0
was	was	VBD	0
recently	recently	RB	0
identified	identified	VBN	0
as	as	IN	0
a	a	DT	0
forth	forth	JJ	0
SCF	SCF	NNP	B-NP
SKP2component	SKP2component	NNP	0
[	[	-LRB-	0
22	22	CD	0
23	23	CD	0
]	]	-RRB-	0
.	.	.	0
Two	Two	CD	0
rate-limiting	rate-limiting	JJ	0
steps	steps	NNS	0
for	for	IN	0
p27	p27	CD	B-NP
ubiquitylation	ubiquitylation	NN	I-NP
were	were	VBD	0
defined	defined	VBN	0
:	:	:	0
(	(	-LRB-	0
1.	1.	CD	0
)	)	-RRB-	0
p27	p27	CD	B-NP
phosphorylation	phosphorylation	NN	I-NP
by	by	IN	0
CDK2	CDK2	CD	B-NP
at	at	IN	0
threonine	threonine	CD	B-NP
187	187	CD	0
[	[	-LRB-	0
24	24	CD	0
25	25	CD	0
26	26	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
(	(	-LRB-	0
2.	2.	NNP	0
)	)	-RRB-	0
binding	binding	NN	0
of	of	IN	0
phosphorylated	phosphorylated	CD	0
p27	p27	CD	B-NP
to	to	TO	0
SKP2	SKP2	CD	B-NP
[	[	-LRB-	0
20	20	CD	0
21	21	CD	0
]	]	-RRB-	0
.	.	.	0
SKP2	SKP2	NNP	B-NP
is	is	VBZ	0
down-regulated	down-regulated	JJ	0
in	in	IN	0
resting	resting	JJ	0
cells	cells	NNS	0
with	with	IN	0
stable	stable	JJ	0
p27	p27	NN	B-NP
,	,	,	0
but	but	CC	0
strongly	strongly	RB	0
up-regulated	up-regulated	JJ	0
in	in	IN	0
cells	cells	NNS	0
,	,	,	0
which	which	WDT	0
progress	progress	NN	0
into	into	IN	0
S	S	NNP	B-NP
phase	phase	NN	I-NP
[	[	-LRB-	0
27	27	CD	0
28	28	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
some	some	DT	0
tissue	tissue	NN	0
culture	culture	NN	0
cells	cells	NNS	0
,	,	,	0
overexpression	overexpression	VBG	0
of	of	IN	0
SKP2	SKP2	NNP	B-NP
is	is	VBZ	0
sufficient	sufficient	JJ	0
to	to	TO	0
induce	induce	VB	0
p27	p27	CD	B-NP
degradation	degradation	NN	I-NP
and	and	CC	0
S	S	NNP	B-NP
phase	phase	NN	I-NP
entry	entry	NN	I-NP
[	[	-LRB-	0
29	29	CD	0
30	30	CD	0
31	31	CD	0
32	32	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
can	can	MD	0
cooperate	cooperate	VB	0
with	with	IN	0
ra	ra	NNP	B-NP
in	in	IN	0
transformation	transformation	NN	B-NP
[	[	-LRB-	0
33	33	CD	0
34	34	CD	0
]	]	-RRB-	0
.	.	.	0
Significantly	Significantly	RB	0
,	,	,	0
overexpression	overexpression	VBG	0
of	of	IN	0
SKP2	SKP2	NNP	B-NP
has	has	VBZ	0
been	been	VBN	0
observed	observed	VBN	0
in	in	IN	0
many	many	JJ	0
cancer	cancer	NN	B-NP
cell	cell	NN	I-NP
line	line	NN	I-NP
[	[	-LRB-	0
28	28	CD	0
35	35	CD	0
]	]	-RRB-	0
as	as	IN	0
well	well	RB	0
as	as	RB	0
in	in	IN	0
primary	primary	JJ	B-NP
cancer	cancer	NN	I-NP
specimen	specimen	NN	I-NP
and	and	CC	0
many	many	JJ	0
of	of	IN	0
these	these	DT	0
tumors	tumors	NNS	0
also	also	RB	0
display	display	VB	0
p27	p27	NNP	B-NP
down-regulation	down-regulation	JJ	I-NP
[	[	-LRB-	0
33	33	CD	0
36	36	CD	0
37	37	CD	0
38	38	CD	0
]	]	-RRB-	0
.	.	.	0
Here	Here	RB	0
,	,	,	0
we	we	PRP	0
used	used	VBD	0
the	the	DT	0
androgen-sensitive	androgen-sensitive	JJ	B-NP
human	human	JJ	0
prostate	prostate	JJ	B-NP
cancer	cancer	NN	I-NP
cell	cell	NN	I-NP
line	line	NN	I-NP
LNCaP	LNCaP	NN	I-NP
[	[	-LRB-	0
39	39	CD	0
]	]	-RRB-	0
as	as	IN	0
a	a	DT	0
model	model	NN	B-NP
system	system	NN	I-NP
to	to	TO	0
address	address	VB	0
the	the	DT	0
role	role	NN	0
of	of	IN	0
SKP2	SKP2	CD	B-NP
in	in	IN	0
androgen-mediated	androgen-mediated	JJ	B-NP
cell	cell	NN	I-NP
cycle	cycle	NN	I-NP
control	control	NN	I-NP
.	.	.	0
This	This	DT	0
cell	cell	NN	0
line	line	NN	0
undergoes	undergoes	VBD	0
reversible	reversible	CD	0
G1	G1	CD	B-NP
arrest	arrest	NN	I-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
androgens	androgens	VB	0
[	[	-LRB-	0
40	40	CD	0
41	41	CD	0
42	42	CD	0
43	43	CD	0
44	44	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
G1	G1	JJ	B-NP
arrest	arrest	NN	I-NP
is	is	VBZ	0
accompanied	accompanied	VBN	0
by	by	IN	0
p27	p27	CD	B-NP
upregulation	upregulation	NN	I-NP
[	[	-LRB-	0
42	42	CD	0
43	43	CD	0
45	45	CD	0
]	]	-RRB-	0
,	,	,	0
however	however	RB	0
the	the	DT	0
pathway	pathway	NN	0
leading	leading	VBG	0
to	to	TO	0
p27	p27	CD	B-NP
upregulation	upregulation	NN	I-NP
is	is	VBZ	0
unknown	unknown	JJ	0
.	.	.	0
We	We	PRP	0
show	show	VBP	0
that	that	IN	0
androgen-induced	androgen-induced	JJ	B-NP
p27	p27	CD	I-NP
upregulation	upregulation	NN	I-NP
is	is	VBZ	0
paralleled	paralleled	VBN	0
by	by	IN	0
p27	p27	CD	B-NP
stabilization	stabilization	NN	I-NP
and	and	CC	0
SKP2	SKP2	CD	B-NP
downregulation	downregulation	NNS	0
.	.	.	0
SKP2	SKP2	NNP	B-NP
overexpression	overexpression	NN	0
is	is	VBZ	0
sufficient	sufficient	JJ	0
to	to	TO	0
overcome	overcome	VB	0
androgen-mediated	androgen-mediated	JJ	B-NP
p27	p27	CD	I-NP
accumulation	accumulation	NN	I-NP
,	,	,	0
indicating	indicating	VBG	0
that	that	IN	0
it	it	PRP	0
is	is	VBZ	0
a	a	DT	0
major	major	JJ	0
mediator	mediator	NN	0
of	of	IN	0
androgen-mediated	androgen-mediated	JJ	B-NP
cell	cell	NN	I-NP
cycle	cycle	NN	I-NP
control	control	NN	I-NP
.	.	.	0
Results	Results	NNS	0
Androgen-induced	Androgen-induced	JJ	B-NP
G1	G1	CD	I-NP
arrest	arrest	NN	I-NP
correlates	correlates	NN	0
with	with	IN	0
inhibition	inhibition	NN	0
of	of	IN	0
cyclin	cyclin	JJ	B-NP
E	E	NN	I-NP
kinase	kinase	NN	I-NP
activity	activity	NN	I-NP
Consistent	Consistent	NNS	0
with	with	IN	0
our	our	PRP$	0
previous	previous	JJ	0
studies	studies	NNS	0
,	,	,	0
the	the	DT	0
synthetic	synthetic	JJ	0
androgen	androgen	JJ	0
7α-17α-dimethyl-19-nortestosterone	7α-17α-dimethyl-19-nortestosterone	NNP	0
(	(	-LRB-	0
mibolerone	mibolerone	UH	B-NP
,	,	,	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
)	)	-RRB-	0
inhibits	inhibits	VBZ	0
the	the	DT	0
proliferation	proliferation	NN	B-NP
and	and	CC	0
suppresses	suppresses	VBG	0
the	the	DT	0
transformed	transformed	JJ	0
lncap	lncap	NN	B-NP
cell	cell	NN	I-NP
phenotype	phenotype	NN	I-NP
(	(	-LRB-	0
[	[	CD	0
46	46	CD	0
]	]	-RRB-	0
and	and	CC	0
Fig.	Fig.	CD	0
1A	1A	CD	0
)	)	-RRB-	0
.	.	.	0
No	No	DT	0
cytotoxic	cytotoxic	NN	B-NP
or	or	CC	0
apoptosis-inducing	apoptosis-inducing	JJ	B-NP
activity	activity	NN	I-NP
was	was	VBD	0
associated	associated	VBN	0
with	with	IN	0
this	this	DT	0
growth	growth	NN	B-NP
inhibition	inhibition	NN	I-NP
(	(	-LRB-	0
[	[	CD	0
46	46	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
To	To	TO	0
determine	determine	VB	0
whether	whether	IN	0
caused	caused	VBD	B-NP
arrest	arrest	NN	I-NP
mitochondria	mitochondria	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
in	in	IN	0
a	a	DT	0
particular	particular	JJ	0
phase	phase	NN	0
of	of	IN	0
the	the	DT	0
cell	cell	NN	B-NP
cycle	cycle	NN	I-NP
,	,	,	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
treated	treated	VBD	0
cells	cells	NNS	0
were	were	VBD	0
examined	examined	VBN	0
by	by	IN	0
flow	flow	NN	B-NP
cytometry	cytometry	NN	I-NP
.	.	.	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
induced	induced	VBD	0
a	a	DT	0
time-dependent	time-dependent	JJ	B-NP
accumulation	accumulation	NN	I-NP
of	of	IN	0
cells	cells	NNS	0
in	in	IN	0
G1	G1	CD	0
at	at	IN	0
the	the	DT	0
expense	expense	NN	0
of	of	IN	0
both	both	DT	0
S	S	NNP	0
and	and	CC	0
G2	G2	NNP	0
/	/	NNP	0
M	M	NNP	0
phases	phases	NNS	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1B	1B	NNP	0
)	)	-RRB-	0
.	.	.	0
Consistent	Consistent	JJ	0
with	with	IN	0
G1	G1	CD	B-NP
arrest	arrest	NN	I-NP
,	,	,	0
induced	induced	VBD	B-NP
inhibition	inhibition	VBN	I-NP
mitochondria	mitochondria	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
of	of	IN	0
cyclin	cyclin	NN	B-NP
E-associated	E-associated	NN	I-NP
H1	H1	NN	I-NP
kinase	kinase	NN	I-NP
activity	activity	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1C	1C	NNP	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
inhibition	inhibition	JJ	B-NP
correlated	correlated	NN	I-NP
with	with	IN	0
increased	increased	JJ	0
recovery	recovery	NN	0
of	of	IN	0
the	the	DT	0
CDK2	CDK2	CD	B-NP
inhibitor	inhibitor	CD	I-NP
p27	p27	CD	I-NP
in	in	IN	0
cyclin	cyclin	JJ	B-NP
E	E	NN	I-NP
immunocomplexes	immunocomplexes	VBZ	0
isolated	isolated	VBN	0
from	from	IN	0
mib-treated	mib-treated	NN	B-NP
lncap	lncap	NN	I-NP
cell	cell	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1D	1D	NNP	0
)	)	-RRB-	0
.	.	.	0
Similar	Similar	JJ	0
finding	finding	NN	0
were	were	VBD	0
previously	previously	RB	0
obtained	obtained	VBN	0
with	with	IN	0
the	the	DT	0
synthetic	synthetic	JJ	B-NP
androgen	androgen	JJ	I-NP
R1881	R1881	NN	0
and	and	CC	0
the	the	DT	0
natural	natural	JJ	0
androgen	androgen	JJ	B-NP
dihydrotestosterona	dihydrotestosterona	NN	I-NP
(	(	-LRB-	0
DHT	DHT	NNP	B-NP
)	)	-RRB-	0
[	[	-LRB-	0
42	42	CD	0
43	43	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
latter	latter	JJ	0
study	study	NN	0
also	also	RB	0
showed	showed	VBD	0
that	that	IN	0
p27	p27	NNP	B-NP
is	is	VBZ	0
quantitatively	quantitatively	VBN	0
bound	bound	VBN	0
to	to	TO	0
cyclin	cyclin	VB	0
e	e	NN	B-NP
complex	complex	JJ	I-NP
in	in	IN	0
dht-treated	dht-treated	NN	B-NP
cell	cell	NN	I-NP
,	,	,	0
indicating	indicating	VBG	0
that	that	IN	0
p27	p27	CD	B-NP
upregulation	upregulation	NN	I-NP
was	was	VBD	0
sufficient	sufficient	JJ	0
to	to	TO	0
saturate	saturate	VB	0
and	and	CC	0
inhibit	inhibit	VB	0
cyclinE	cyclinE	JJ	0
/	/	CD	0
cdk2	cdk2	NN	B-NP
complex	complex	JJ	I-NP
[	[	-LRB-	0
43	43	CD	0
]	]	-RRB-	0
.	.	.	0
MIB-induced	MIB-induced	JJ	B-NP
cell	cell	NN	I-NP
cycle	cycle	NN	I-NP
arrest	arrest	NN	I-NP
and	and	CC	0
CDK2	CDK2	CD	B-NP
inhibition	inhibition	JJ	I-NP
coincide	coincide	NN	0
with	with	IN	0
p27	p27	NNP	B-NP
upregulation	upregulation	NN	I-NP
and	and	CC	0
downregulation	downregulation	NN	B-NP
of	of	IN	0
SKP2	SKP2	NNP	B-NP
Consistent	Consistent	NNP	0
with	with	IN	0
increased	increased	JJ	0
recovery	recovery	NN	0
of	of	IN	0
p27	p27	CD	B-NP
in	in	IN	0
cyclin	cyclin	JJ	B-NP
e	e	NN	I-NP
complex	complex	JJ	I-NP
,	,	,	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
caused	caused	VBD	0
a	a	DT	0
concentration	concentration	NN	B-NP
and	and	CC	0
time-dependent	time-dependent	JJ	B-NP
increase	increase	NN	I-NP
in	in	IN	0
steady-state	steady-state	JJ	B-NP
p27	p27	CD	I-NP
protein	protein	NN	I-NP
level	level	JJ	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2A	2A	NNP	0
,	,	,	0
2B	2B	CD	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
increase	increase	NN	0
was	was	VBD	0
reversible	reversible	JJ	0
,	,	,	0
as	as	IN	0
p27	p27	CD	B-NP
level	level	JJ	I-NP
were	were	VBD	0
gradually	gradually	RB	0
restored	restored	VBN	0
to	to	TO	0
near	near	JJ	0
control	control	NN	B-NP
level	level	JJ	I-NP
after	after	IN	0
removal	removal	NN	0
of	of	IN	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
and	and	CC	0
addition	addition	NN	B-NP
of	of	IN	0
a	a	DT	0
500-fold	500-fold	JJ	0
antiandrogen	antiandrogen	NN	B-NP
cyproterone	cyproterone	NN	I-NP
acetate	acetate	NN	I-NP
molar	molar	JJ	I-NP
excess	excess	NN	I-NP
(	(	-LRB-	0
CA	CA	NNP	B-NP
)	)	-RRB-	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
2Cand	2Cand	CD	0
2D	2D	CD	0
)	)	-RRB-	0
.	.	.	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
simultaneous	simultaneous	JJ	I-NP
administration	administration	NN	I-NP
and	and	CC	0
cyproterone	cyproterone	NN	B-NP
acetate	acetate	NN	I-NP
partially	partially	RB	0
prevented	prevented	VBD	B-NP
p27	p27	CD	I-NP
accumulation	accumulation	NN	I-NP
,	,	,	0
indicating	indicating	VBG	0
that	that	IN	0
it	it	PRP	0
was	was	VBD	0
mediated	mediated	VBN	0
by	by	IN	0
the	the	DT	0
androgen	androgen	JJ	B-NP
receptor	receptor	NN	I-NP
(	(	-LRB-	0
AR	AR	NNP	B-NP
)	)	-RRB-	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2D	2D	NNP	0
)	)	-RRB-	0
.	.	.	0
Since	Since	IN	0
the	the	DT	0
level	level	NN	0
of	of	IN	0
SKP2	SKP2	NNP	B-NP
is	is	VBZ	0
a	a	DT	0
rate-limiting	rate-limiting	JJ	0
p27	p27	CD	B-NP
level	level	JJ	I-NP
determinant	determinant	NN	I-NP
[	[	-LRB-	0
20	20	CD	0
21	21	CD	0
29	29	CD	0
]	]	-RRB-	0
,	,	,	0
we	we	PRP	0
examined	examined	VBD	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
on	on	IN	0
SKP2	SKP2	CD	B-NP
protein	protein	NN	0
levels	levels	NNS	0
.	.	.	0
SKP2	SKP2	NNP	B-NP
levels	levels	NNS	0
were	were	VBD	0
down-regulated	down-regulated	JJ	0
nearly	nearly	RB	0
four-fold	four-fold	RB	B-NP
by	by	IN	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
at	at	IN	0
concentration	concentration	NN	B-NP
and	and	CC	0
with	with	IN	0
kinetics	kinetics	NNS	0
that	that	WDT	0
closely	closely	RB	0
paralleled	paralleled	CD	0
p27	p27	CD	B-NP
accumulation	accumulation	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2A	2A	NNP	0
,	,	,	0
2B	2B	CD	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
downregulation	downregulation	VBG	0
of	of	IN	0
RB1	RB1	NNP	B-NP
and	and	CC	0
accumulation	accumulation	NN	B-NP
in	in	IN	0
the	the	DT	0
underphosphorylated	underphosphorylated	JJ	B-NP
form	form	NN	I-NP
paralleled	paralleled	FW	0
SKP2	SKP2	NN	B-NP
down-regulation	down-regulation	FW	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2A	2A	NNP	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
contrast	contrast	NN	0
,	,	,	0
only	only	RB	0
minor	minor	JJ	0
changes	changes	NNS	0
were	were	VBD	0
detected	detected	VBN	0
in	in	IN	0
the	the	DT	0
expression	expression	NN	0
of	of	IN	0
the	the	DT	0
SKP2-associated	SKP2-associated	NNP	0
SCF	SCF	NNP	B-NP
SKP2subunits	SKP2subunits	NNP	0
HRT1	HRT1	NNP	0
,	,	,	0
cullin	cullin	NNP	B-NP
1	1	NN	I-NP
,	,	,	0
and	and	CC	0
SKP1	SKP1	NNP	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2A	2A	NNP	0
)	)	-RRB-	0
.	.	.	0
MIB-dependent	MIB-dependent	NNP	0
SKP2	SKP2	NNP	B-NP
down-regulation	down-regulation	NNP	0
was	was	VBD	0
efficiently	efficiently	RB	0
counteracted	counteracted	VBN	0
by	by	IN	0
cyproterone	cyproterone	NN	B-NP
acetate	acetate	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
2Cand	2Cand	CD	0
2D	2D	CD	0
)	)	-RRB-	0
,	,	,	0
again	again	RB	0
indicating	indicating	VBG	0
an	an	DT	0
involvement	involvement	NN	0
of	of	IN	0
the	the	DT	0
androgen	androgen	NN	B-NP
receptor	receptor	NN	I-NP
.	.	.	0
Cyclin	Cyclin	NNP	B-NP
A	A	NNP	0
,	,	,	0
but	but	CC	0
not	not	RB	0
cyclin	cyclin	JJ	B-NP
e	e	NN	I-NP
level	level	JJ	I-NP
were	were	VBD	0
also	also	RB	0
suppressed	suppressed	VBN	0
by	by	IN	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
in	in	IN	0
an	an	DT	0
AR-dependent	AR-dependent	JJ	B-NP
manner	manner	NN	I-NP
,	,	,	0
while	while	IN	0
the	the	DT	0
levels	levels	NNS	0
of	of	IN	0
the	the	DT	0
COP9	COP9	NN	B-NP
/	/	FW	0
signalosome	signalosome	NN	B-NP
subunit	subunit	NN	I-NP
CSN5	CSN5	NN	I-NP
/	/	FW	0
JAB1	JAB1	NN	B-NP
and	and	CC	0
tubulin	tubulin	NN	B-NP
remained	remained	VBD	0
constant	constant	JJ	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2D	2D	NNP	0
)	)	-RRB-	0
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
consistent	consistent	JJ	0
with	with	IN	0
SKP2	SKP2	NNP	B-NP
and	and	CC	0
p27	p27	RB	0
being	being	VBG	0
lncap	lncap	NN	B-NP
cell	cell	NN	I-NP
androgen-mediated	androgen-mediated	JJ	I-NP
growth	growth	NN	I-NP
control	control	NN	I-NP
integral	integral	JJ	I-NP
component	component	JJ	I-NP
,	,	,	0
cyproterone	cyproterone	NN	B-NP
acetate	acetate	NN	I-NP
also	also	RB	0
efficiently	efficiently	RB	0
reversed	reversed	VBD	0
the	the	DT	0
MIB-induced	MIB-induced	JJ	B-NP
G1	G1	CD	I-NP
cell	cell	NN	I-NP
cycle	cycle	NN	I-NP
arrest	arrest	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2E	2E	NNP	0
)	)	-RRB-	0
.	.	.	0
To	To	TO	0
confirm	confirm	VB	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
on	on	IN	0
p27	p27	NNP	B-NP
and	and	CC	0
SKP2	SKP2	CD	B-NP
at	at	IN	0
the	the	DT	0
level	level	NN	0
of	of	IN	0
individual	individual	JJ	B-NP
cell	cell	NN	I-NP
,	,	,	0
we	we	PRP	0
performed	performed	VBD	0
immunofluorescence	immunofluorescence	JJ	B-NP
staining	staining	NN	I-NP
.	.	.	0
In	In	IN	0
untreated	untreated	JJ	0
controls	controls	NNS	0
,	,	,	0
most	most	JJS	0
cells	cells	NNS	0
displayed	displayed	VBD	0
strong	strong	JJ	0
staining	staining	NN	0
for	for	IN	0
SKP2	SKP2	CD	B-NP
with	with	IN	0
few	few	JJ	0
cells	cells	NNS	0
positive	positive	JJ	0
for	for	IN	0
p27	p27	NNP	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2F	2F	NNP	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
nuclear	nuclear	JJ	0
staining	staining	JJ	0
patterns	patterns	NNS	0
of	of	IN	0
SKP2	SKP2	NNP	B-NP
and	and	CC	0
p27	p27	NNP	B-NP
appeared	appeared	VBD	0
mutually	mutually	RB	0
exclusive	exclusive	JJ	B-NP
.	.	.	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2F	2F	NNP	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
contrast	contrast	NN	0
,	,	,	0
the	the	DT	0
majority	majority	NN	0
of	of	IN	0
mib-treated	mib-treated	NN	B-NP
cell	cell	NN	I-NP
showed	showed	VBD	0
strong	strong	JJ	0
p27	p27	CD	B-NP
expression	expression	NN	I-NP
,	,	,	0
while	while	IN	0
only	only	RB	0
few	few	JJ	0
cells	cells	NNS	0
were	were	VBD	0
positive	positive	JJ	0
for	for	IN	0
SKP2	SKP2	CD	B-NP
.	.	.	0
MIB-induced	MIB-induced	NNP	B-NP
p27	p27	NNP	I-NP
upregulation	upregulation	VBD	0
correlates	correlates	VBN	0
with	with	IN	0
increased	increased	JJ	0
p27	p27	CD	B-NP
protein	protein	NN	I-NP
stability	stability	NN	I-NP
and	and	CC	0
decreased	decreased	VBD	0
ubiquitylation	ubiquitylation	JJ	B-NP
Northern	Northern	JJ	I-NP
blot	blot	JJ	I-NP
analysis	analysis	NN	I-NP
revealed	revealed	VBD	0
that	that	DT	0
MIB-induced	MIB-induced	JJ	0
SKP2	SKP2	CD	B-NP
downregulation	downregulation	NN	0
at	at	IN	0
the	the	DT	0
protein	protein	NN	B-NP
level	level	NN	I-NP
is	is	VBZ	0
reflected	reflected	VBN	0
by	by	IN	0
quantitatively	quantitatively	JJ	0
similar	similar	JJ	0
changes	changes	NNS	0
in	in	IN	0
steady	steady	JJ	0
state	state	NN	B-NP
rna	rna	NN	I-NP
level	level	JJ	I-NP
(	(	-LRB-	0
Fig	Fig	NNP	0
3A	3A	NNP	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
contrast	contrast	NN	0
,	,	,	0
p27	p27	CD	B-NP
mrna	mrna	NN	I-NP
level	level	JJ	I-NP
were	were	VBD	0
upregulated	upregulated	VBN	0
by	by	IN	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
only	only	RB	0
two-fold	two-fold	JJ	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3A	3A	NNP	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
suggested	suggested	VBN	0
that	that	IN	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
on	on	IN	0
p27	p27	NNP	B-NP
rna	rna	NN	I-NP
level	level	JJ	I-NP
can	can	MD	0
not	not	RB	0
fully	fully	RB	0
account	account	VBP	0
for	for	IN	0
the	the	DT	0
p27	p27	CD	B-NP
protein	protein	NN	I-NP
accumulation	accumulation	NN	I-NP
(	(	-LRB-	0
compare	compare	FW	0
Figs.	Figs.	FW	0
2Band	2Band	FW	0
3A	3A	FW	0
)	)	-RRB-	0
We	We	PRP	0
therefore	therefore	RB	0
determined	determined	VBN	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
on	on	IN	0
p27	p27	CD	B-NP
half-life	half-life	NN	I-NP
.	.	.	0
Protein	Protein	NN	B-NP
synthesis	synthesis	NN	I-NP
was	was	VBD	0
inhibited	inhibited	VBN	0
by	by	IN	0
cycloheximide	cycloheximide	NN	B-NP
in	in	IN	0
control	control	NN	B-NP
cell	cell	NN	I-NP
and	and	CC	0
in	in	IN	0
cells	cells	NNS	0
pretreated	pretreated	VBN	0
with	with	IN	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
for	for	IN	0
72	72	CD	0
h.	h.	NN	B-NP
cell	cell	NN	I-NP
were	were	VBD	0
harvested	harvested	VBN	0
after	after	IN	0
various	various	JJ	0
times	times	NNS	0
and	and	CC	0
the	the	DT	0
effect	effect	NN	0
on	on	IN	0
p27	p27	CD	B-NP
protein	protein	NN	I-NP
level	level	JJ	I-NP
was	was	VBD	0
assessed	assessed	VBN	0
by	by	IN	0
immunoblotting	immunoblotting	NN	B-NP
.	.	.	0
Using	Using	VBG	0
this	this	DT	0
assay	assay	NN	B-NP
,	,	,	0
we	we	PRP	0
determined	determined	VBD	0
a	a	DT	0
p27	p27	JJ	B-NP
half-life	half-life	NN	I-NP
of	of	IN	0
4	4	CD	0
h	h	NN	0
in	in	IN	0
control	control	NN	B-NP
cell	cell	NN	I-NP
,	,	,	0
which	which	WDT	0
was	was	VBD	0
increased	increased	VBN	0
to	to	TO	0
more	more	JJR	0
than	than	IN	0
6	6	CD	0
h	h	NN	0
in	in	IN	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
treated	treated	VBD	0
cells	cells	NNS	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3B	3B	NNP	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
experiment	experiment	NN	0
likely	likely	RB	0
overestimates	overestimates	CD	0
p27	p27	CD	B-NP
half-life	half-life	NN	I-NP
in	in	IN	0
untreated	untreated	JJ	0
cells	cells	NNS	0
,	,	,	0
as	as	IN	0
SKP2	SKP2	NNP	B-NP
was	was	VBD	0
itself	itself	PRP	0
downregulated	downregulated	VBD	0
by	by	IN	0
CHX	CHX	NNP	B-NP
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
Nevertheless	Nevertheless	RB	0
,	,	,	0
the	the	DT	0
data	data	NNS	0
suggest	suggest	VBP	0
that	that	IN	0
p27	p27	CD	B-NP
upregulation	upregulation	NN	I-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
is	is	VBZ	0
partially	partially	RB	0
mediated	mediated	VBN	0
by	by	IN	0
changes	changes	NNS	0
in	in	IN	0
protein	protein	NN	B-NP
stability	stability	NN	I-NP
.	.	.	0
To	To	TO	0
confirm	confirm	VB	0
this	this	DT	0
conjecture	conjecture	NN	B-NP
,	,	,	0
we	we	PRP	0
used	used	VBD	0
an	an	DT	0
in	in	IN	0
vitro	vitro	JJ	B-NP
assay	assay	NN	I-NP
to	to	TO	0
determine	determine	VB	0
p27	p27	CD	B-NP
ubiquitylation	ubiquitylation	JJ	I-NP
activity	activity	NN	I-NP
in	in	IN	0
LNCaP	LNCaP	JJ	B-NP
cell	cell	NN	I-NP
lysate	lysate	NN	I-NP
.	.	.	0
Similar	Similar	JJ	0
to	to	TO	0
previously	previously	RB	0
described	described	VBN	0
protocols	protocols	NNS	0
[	[	-LRB-	0
21	21	CD	0
22	22	CD	0
30	30	CD	0
]	]	-RRB-	0
,	,	,	0
cell	cell	NN	B-NP
lysate	lysate	NN	I-NP
were	were	VBD	0
prepared	prepared	VBN	0
by	by	IN	0
hypotonic	hypotonic	JJ	B-NP
lysi	lysi	NN	I-NP
of	of	IN	0
untreated	untreated	JJ	0
lncap	lncap	NN	B-NP
cell	cell	NN	I-NP
or	or	CC	0
cells	cells	NNS	0
treated	treated	VBN	0
with	with	IN	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
for	for	IN	0
96	96	CD	0
h	h	NNS	0
.	.	.	0
Ubiquitylation	Ubiquitylation	JJ	B-NP
substrate	substrate	NN	I-NP
was	was	VBD	0
prepared	prepared	VBN	0
by	by	IN	0
in	in	IN	0
vitro	vitro	JJ	B-NP
transcription	transcription	NN	I-NP
and	and	CC	0
translation	translation	NN	0
of	of	IN	0
p27	p27	CD	B-NP
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
35S-methionine	35S-methionine	CD	0
.	.	.	0
A	A	DT	0
p27	p27	NNP	B-NP
point	point	NN	I-NP
mutant	mutant	NN	I-NP
(	(	-LRB-	0
p27T187A	p27T187A	NNP	0
)	)	-RRB-	0
,	,	,	0
in	in	IN	0
which	which	WDT	0
the	the	DT	0
critical	critical	JJ	B-NP
CDK2	CDK2	CD	I-NP
phosphorylation	phosphorylation	JJ	I-NP
site	site	NN	I-NP
in	in	IN	0
position	position	NN	0
187	187	CD	0
was	was	VBD	0
replaced	replaced	VBN	0
by	by	IN	0
alanina	alanina	NN	B-NP
[	[	-LRB-	0
24	24	CD	0
]	]	-RRB-	0
was	was	VBD	0
also	also	RB	0
prepared	prepared	VBN	0
.	.	.	0
Both	Both	DT	0
substrates	substrates	NN	0
were	were	VBD	0
incubated	incubated	VBN	0
with	with	IN	0
recombinant	recombinant	JJ	0
cyclin	cyclin	JJ	B-NP
E	E	NN	I-NP
/	/	CD	0
cdk2	cdk2	NN	B-NP
complex	complex	JJ	I-NP
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
ATP	ATP	NNP	B-NP
,	,	,	0
ubiquitin	ubiquitin	NN	B-NP
,	,	,	0
and	and	CC	0
LNCaP	LNCaP	JJ	B-NP
cell	cell	NN	I-NP
lysate	lysate	NN	I-NP
.	.	.	0
Conversion	Conversion	NN	0
of	of	IN	0
p27	p27	CD	B-NP
into	into	IN	0
polyubiquitylated	polyubiquitylated	JJ	B-NP
high	high	JJ	I-NP
molecular	molecular	JJ	I-NP
weight	weight	NN	I-NP
specie	specie	NN	I-NP
was	was	VBD	0
monitored	monitored	VBN	0
by	by	IN	0
autoradiography	autoradiography	NN	B-NP
of	of	IN	0
35S-labeled	35S-labeled	CD	0
p27	p27	CD	0
following	following	JJ	0
gel	gel	JJ	B-NP
electrophoresi	electrophoresi	NN	I-NP
.	.	.	0
wildtype	wildtype	NN	B-NP
polyubiquitylation	polyubiquitylation	NN	I-NP
,	,	,	0
but	but	CC	0
not	not	RB	0
mutant	mutant	JJ	B-NP
p27	p27	NN	I-NP
was	was	VBD	0
observed	observed	VBN	0
in	in	IN	0
untreated	untreated	JJ	0
LNCaP	LNCaP	JJ	B-NP
cell	cell	NN	I-NP
lysata	lysata	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3C	3C	NNP	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
activity	activity	NN	0
was	was	VBD	0
completely	completely	RB	0
abolished	abolished	VBN	0
in	in	IN	0
mib-treated	mib-treated	NN	B-NP
cell	cell	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3C	3C	NNP	0
)	)	-RRB-	0
,	,	,	0
suggesting	suggesting	VBG	0
that	that	IN	0
p27	p27	CD	B-NP
accumulation	accumulation	NN	I-NP
result	result	NN	I-NP
from	from	IN	0
reduced	reduced	JJ	0
p27	p27	CD	B-NP
ubiquitylation	ubiquitylation	NN	I-NP
.	.	.	0
Overexpression	Overexpression	NNP	B-NP
of	of	IN	0
SKP2	SKP2	NNP	B-NP
induces	induces	VBZ	0
F-box-dependent	F-box-dependent	JJ	B-NP
p27	p27	NN	I-NP
ubiquitylation	ubiquitylation	VBZ	0
Considering	Considering	VBG	0
the	the	DT	0
inverse	inverse	JJ	B-NP
correlation	correlation	NN	I-NP
between	between	IN	0
p27	p27	NNP	B-NP
and	and	CC	0
SKP2	SKP2	CD	B-NP
protein	protein	NN	0
levels	levels	NNS	0
,	,	,	0
we	we	PRP	0
asked	asked	VBD	0
whether	whether	IN	0
ectopic	ectopic	JJ	0
SKP2	SKP2	NN	B-NP
can	can	MD	0
forge	forge	VB	0
p27	p27	CD	B-NP
down-regulation	down-regulation	NN	I-NP
in	in	IN	0
lncap	lncap	NN	B-NP
cell	cell	NN	I-NP
.	.	.	0
To	To	TO	0
test	test	VB	0
this	this	DT	0
,	,	,	0
we	we	PRP	0
generated	generated	VBD	0
recombinant	recombinant	JJ	0
adenoviru	adenoviru	NN	B-NP
driving	driving	VBG	0
the	the	DT	0
expression	expression	NN	0
of	of	IN	0
SKP2	SKP2	NNP	B-NP
(	(	-LRB-	0
Ad-SKP2	Ad-SKP2	NNP	B-NP
)	)	-RRB-	0
or	or	CC	0
a	a	DT	0
mutant	mutant	NN	B-NP
of	of	IN	0
SKP2	SKP2	CD	B-NP
lacking	lacking	VBG	0
the	the	DT	0
F-box	F-box	JJ	B-NP
(	(	-LRB-	0
Ad-SKP2-ΔF	Ad-SKP2-ΔF	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
asynchronous	asynchronous	JJ	B-NP
lncap	lncap	NN	I-NP
cell	cell	NN	I-NP
infection	infection	NN	I-NP
with	with	IN	0
SKP2	SKP2	CD	B-NP
virus	virus	NN	0
led	led	VBD	0
to	to	TO	0
p27	p27	NNP	B-NP
time-dependent	time-dependent	JJ	I-NP
downregulation	downregulation	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
4A	4A	NNP	0
)	)	-RRB-	0
.	.	.	0
To	To	TO	0
determine	determine	VB	0
whether	whether	IN	0
SKP2	SKP2	CD	B-NP
downregulation	downregulation	NN	0
is	is	VBZ	0
a	a	DT	0
necessary	necessary	JJ	0
step	step	NN	0
in	in	IN	0
MIB-induced	MIB-induced	JJ	B-NP
p27	p27	CD	I-NP
upregulation	upregulation	NN	I-NP
,	,	,	0
lncap	lncap	NN	B-NP
cell	cell	NN	I-NP
were	were	VBD	0
blocked	blocked	VBN	0
with	with	IN	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
for	for	IN	0
72	72	CD	0
h	h	NN	0
,	,	,	0
followed	followed	VBN	0
by	by	IN	0
infection	infection	NN	B-NP
with	with	IN	0
Ad-SKP2	Ad-SKP2	NNP	B-NP
or	or	CC	0
Ad-SKP2-ΔF	Ad-SKP2-ΔF	CD	B-NP
for	for	IN	0
various	various	JJ	0
periods	periods	NNS	0
.	.	.	0
Immunoblotting	Immunoblotting	NNP	B-NP
revealed	revealed	VBD	0
that	that	IN	0
SKP2	SKP2	CD	B-NP
overexpression	overexpression	NNS	0
can	can	MD	0
efficiently	efficiently	RB	0
downregulate	downregulate	CD	B-NP
p27	p27	CD	I-NP
level	level	JJ	I-NP
in	in	IN	0
the	the	DT	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
continuous	continuous	JJ	I-NP
presence	presence	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
4B	4B	NNP	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
contrast	contrast	NN	0
,	,	,	0
overexpression	overexpression	VBG	0
of	of	IN	0
F-box	F-box	JJ	B-NP
deleted	deleted	JJ	0
SKP2	SKP2	NN	B-NP
did	did	VBD	0
not	not	RB	0
result	result	VB	0
in	in	IN	0
a	a	DT	0
decline	decline	NN	0
of	of	IN	0
p27	p27	NNP	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
4B	4B	NNP	0
)	)	-RRB-	0
.	.	.	0
To	To	TO	0
determine	determine	VB	0
whether	whether	IN	0
SKP2	SKP2	CD	B-NP
induces	induces	CD	0
p27	p27	CD	B-NP
ubiquitylation	ubiquitylation	NN	I-NP
,	,	,	0
cell	cell	NN	B-NP
lysata	lysata	NN	I-NP
was	was	VBD	0
prepared	prepared	VBN	0
from	from	IN	0
mib-exposed	mib-exposed	NN	B-NP
cell	cell	NN	I-NP
infected	infected	VBN	0
with	with	IN	0
Ad-SKP2	Ad-SKP2	NNP	B-NP
and	and	CC	0
Ad-SKP2-ΔF	Ad-SKP2-ΔF	NNP	B-NP
,	,	,	0
and	and	CC	0
supplemented	supplemented	NN	0
with	with	IN	0
phosphorylated	phosphorylated	CD	0
p27	p27	CD	B-NP
,	,	,	0
ATP	ATP	NNP	B-NP
,	,	,	0
and	and	CC	0
ubiquitin	ubiquitin	NN	B-NP
.	.	.	0
SKP	SKP	NNP	B-NP
overexpression	overexpression	NN	0
for	for	IN	0
24	24	CD	0
or	or	CC	0
48	48	CD	0
h	h	NNS	0
dramatically	dramatically	RB	0
increased	increased	VBD	B-NP
p27	p27	CD	I-NP
ubiquitylation	ubiquitylation	JJ	I-NP
activity	activity	NN	I-NP
present	present	NN	0
in	in	IN	0
these	these	DT	0
cell	cell	NN	B-NP
lysate	lysate	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
4C	4C	NNP	0
,	,	,	0
lane	lane	CD	0
5	5	CD	0
and	and	CC	0
7	7	CD	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
increase	increase	NN	0
was	was	VBD	0
not	not	RB	0
observed	observed	VBN	0
with	with	IN	0
mutant	mutant	JJ	0
p27T187A	p27T187A	NN	0
as	as	IN	0
substrate	substrate	NN	0
and	and	CC	0
upon	upon	IN	0
skp-δf	skp-δf	NN	B-NP
overexpression	overexpression	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
4C	4C	NNP	0
,	,	,	0
lanes	lanes	CD	0
9	9	CD	0
and	and	CC	0
11	11	CD	0
)	)	-RRB-	0
.	.	.	0
Overexpression	Overexpression	NNP	B-NP
of	of	IN	0
SKP2	SKP2	NNP	B-NP
is	is	VBZ	0
not	not	RB	0
sufficient	sufficient	JJ	0
to	to	TO	0
overcome	overcome	VB	0
androgen-mediated	androgen-mediated	JJ	B-NP
G1	G1	CD	I-NP
arrest	arrest	NN	I-NP
To	To	TO	0
test	test	VB	0
whether	whether	IN	0
SKP2-mediated	SKP2-mediated	CD	B-NP
p27	p27	CD	I-NP
degradation	degradation	NN	I-NP
is	is	VBZ	0
sufficient	sufficient	JJ	0
to	to	TO	0
overcome	overcome	VB	0
the	the	DT	0
MIB-induced	MIB-induced	JJ	B-NP
G1	G1	CD	I-NP
cell	cell	NN	I-NP
cycle	cycle	NN	I-NP
arrest	arrest	NN	I-NP
,	,	,	0
lncap	lncap	NN	B-NP
cell	cell	NN	I-NP
were	were	VBD	0
arrested	arrested	VBN	0
with	with	IN	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
for	for	IN	0
72	72	CD	0
h	h	NN	0
,	,	,	0
followed	followed	VBN	0
by	by	IN	0
infection	infection	NN	B-NP
with	with	IN	0
SKP2	SKP2	CD	B-NP
adenovirus	adenovirus	NNS	0
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
harvested	harvested	VBN	0
and	and	CC	0
analyzed	analyzed	VBD	0
by	by	IN	0
flow	flow	NN	B-NP
cytometry	cytometry	NN	I-NP
after	after	IN	0
various	various	JJ	0
periods	periods	NNS	0
.	.	.	0
The	The	DT	0
mutant	mutant	JJ	B-NP
SKP2-ΔF	SKP2-ΔF	NN	I-NP
was	was	VBD	0
used	used	VBN	0
as	as	IN	0
a	a	DT	0
negative	negative	JJ	B-NP
control	control	NN	I-NP
.	.	.	0
Although	Although	IN	0
,	,	,	0
in	in	IN	0
three	three	CD	0
independent	independent	JJ	0
experiments	experiments	NNS	0
,	,	,	0
the	the	DT	0
fraction	fraction	NN	B-NP
of	of	IN	0
cells	cells	NNS	0
in	in	IN	0
S	S	NNP	B-NP
phase	phase	NN	I-NP
was	was	VBD	0
significantly	significantly	RB	0
(	(	-LRB-	0
p	p	CD	0
=	=	SYM	0
0.009	0.009	CD	0
)	)	-RRB-	0
higher	higher	JJR	0
in	in	IN	0
mib-arrested	mib-arrested	NN	B-NP
cell	cell	NN	I-NP
overexpressing	overexpressing	VBD	0
SKP2	SKP2	CD	B-NP
(	(	-LRB-	0
7.93	7.93	CD	0
%	%	NN	0
,	,	,	0
+	+	CD	0
/	/	CD	0
-0.32	-0.32	CD	0
)	)	-RRB-	0
than	than	IN	0
in	in	IN	0
skp2-δf	skp2-δf	NN	B-NP
overexpressing	overexpressing	CD	I-NP
cell	cell	NN	I-NP
(	(	-LRB-	0
4.02	4.02	NNP	0
%	%	NN	0
,	,	,	0
+	+	CD	0
/	/	CD	0
-1.41	-1.41	CD	0
)	)	-RRB-	0
at	at	IN	0
a	a	DT	0
time	time	NN	0
when	when	WRB	0
p27	p27	JJ	B-NP
downregulation	downregulation	NN	I-NP
was	was	VBD	0
already	already	RB	0
apparent	apparent	JJ	0
(	(	-LRB-	0
24	24	CD	0
h	h	CD	0
)	)	-RRB-	0
,	,	,	0
the	the	DT	0
majority	majority	NN	0
of	of	IN	0
cells	cells	NNS	0
remained	remained	VBD	0
tightly	tightly	RB	0
arrested	arrested	VBN	0
in	in	IN	0
G1	G1	CD	0
over	over	IN	0
the	the	DT	0
entire	entire	JJ	0
72	72	CD	0
h	h	JJ	B-NP
course	course	NN	I-NP
of	of	IN	0
the	the	DT	0
experiment	experiment	NN	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
5A	5A	NNP	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
finding	finding	NN	0
is	is	VBZ	0
in	in	IN	0
contrast	contrast	NN	0
to	to	TO	0
starved	starved	VBN	B-NP
rat	rat	JJ	I-NP
fibroblast	fibroblast	NN	I-NP
serum	serum	VB	I-NP
and	and	CC	0
human	human	JJ	0
u87	u87	NN	B-NP
cell	cell	NN	I-NP
arrested	arrested	VBN	0
in	in	IN	0
G1	G1	CD	0
by	by	IN	0
pten	pten	NN	B-NP
overexpression	overexpression	NN	I-NP
,	,	,	0
in	in	IN	0
which	which	WDT	0
SKP2	SKP2	CD	B-NP
overexpression	overexpression	NNS	0
can	can	MD	0
drive	drive	VB	0
S	S	NNP	B-NP
phase	phase	NN	I-NP
entry.	entry.	NN	I-NP
[	[	-LRB-	0
29	29	CD	0
30	30	CD	0
32	32	CD	0
33	33	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
both	both	DT	0
cases	cases	NNS	0
,	,	,	0
SKP2	SKP2	CD	B-NP
overexpression	overexpression	NN	0
leads	leads	VBZ	0
to	to	TO	0
induction	induction	VB	B-NP
of	of	IN	0
cyclin	cyclin	JJ	0
A	A	NN	0
and	and	CC	0
CDK2	CDK2	CD	B-NP
kinase	kinase	JJ	I-NP
activity	activity	NN	I-NP
.	.	.	0
We	We	PRP	0
therefore	therefore	RB	0
asked	asked	VBN	0
whether	whether	IN	0
SKP2-mediated	SKP2-mediated	CD	B-NP
p27	p27	CD	I-NP
downregulation	downregulation	NN	I-NP
in	in	IN	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
arrested	arrested	VBN	0
lncap	lncap	NN	B-NP
cell	cell	NN	I-NP
was	was	VBD	0
able	able	JJ	0
to	to	TO	0
actually	actually	RB	0
bring	bring	VB	0
about	about	IN	0
CDK2	CDK2	CD	B-NP
activation	activation	NN	I-NP
.	.	.	0
We	We	PRP	0
first	first	RB	0
determined	determined	VBN	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
SKP2	SKP2	CD	B-NP
overexpression	overexpression	NN	0
on	on	IN	0
MIB-induced	MIB-induced	JJ	B-NP
RB1	RB1	CD	I-NP
downregulation	downregulation	NN	I-NP
and	and	CC	0
accumulation	accumulation	NN	B-NP
in	in	IN	0
the	the	DT	0
dephosphorylated	dephosphorylated	JJ	B-NP
state	state	NN	I-NP
(	(	-LRB-	0
see	see	VB	0
Fig.	Fig.	CD	0
2A	2A	CD	0
)	)	-RRB-	0
,	,	,	0
which	which	WDT	0
is	is	VBZ	0
carried	carried	VBN	0
out	out	RP	0
by	by	IN	0
CDK2	CDK2	CD	B-NP
in	in	IN	0
vivo	vivo	NN	B-NP
[	[	-LRB-	0
47	47	CD	0
]	]	-RRB-	0
.	.	.	0
Immunoblotting	Immunoblotting	NNP	B-NP
revealed	revealed	VBD	0
that	that	IN	0
RB1	RB1	CD	B-NP
suppression	suppression	NN	I-NP
in	in	IN	0
the	the	DT	0
hypophosphorylated	hypophosphorylated	JJ	B-NP
state	state	NN	I-NP
was	was	VBD	0
efficiently	efficiently	RB	0
reversed	reversed	VBN	0
by	by	IN	0
SKP2	SKP2	CD	B-NP
overexpression	overexpression	NN	0
for	for	IN	0
24	24	CD	0
or	or	CC	0
48	48	CD	0
h	h	NNS	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
5B	5B	NNP	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
cyclin	cyclin	VBG	0
A	A	DT	0
expression	expression	NN	0
was	was	VBD	0
partially	partially	RB	0
restored	restored	VBN	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
5B	5B	NNP	0
)	)	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
both	both	DT	0
effects	effects	NNS	0
were	were	VBD	0
largely	largely	RB	0
annihilated	annihilated	VBN	0
after	after	IN	0
72	72	CD	0
h	h	NN	0
of	of	IN	0
SKP2	SKP2	CD	B-NP
overexpression	overexpression	NNS	0
.	.	.	0
In	In	IN	0
contrast	contrast	NN	0
,	,	,	0
cyclin	cyclin	JJ	B-NP
e	e	NN	I-NP
level	level	JJ	I-NP
,	,	,	0
while	while	IN	0
not	not	RB	0
initially	initially	RB	0
affected	affected	VBN	0
by	by	IN	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
,	,	,	0
were	were	VBD	0
decreased	decreased	VBN	0
after	after	IN	0
72	72	CD	0
h	h	NN	0
of	of	IN	0
SKP2	SKP2	CD	B-NP
overexpression	overexpression	NNS	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
5B	5B	NNP	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
contrast	contrast	NN	0
,	,	,	0
CDK2	CDK2	NNP	B-NP
and	and	CC	0
tubulin	tubulin	JJ	B-NP
level	level	JJ	I-NP
remained	remained	VBD	0
stable	stable	JJ	0
at	at	IN	0
all	all	DT	0
time	time	NN	B-NP
point	point	NN	I-NP
of	of	IN	0
SKP2	SKP2	CD	B-NP
overexpression	overexpression	NNS	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
5B	5B	NNP	0
)	)	-RRB-	0
.	.	.	0
A	A	DT	0
parallel	parallel	JJ	0
experiment	experiment	NN	0
,	,	,	0
revealed	revealed	VBD	0
that	that	IN	0
CDK2	CDK2	CD	B-NP
kinase	kinase	JJ	I-NP
activity	activity	NN	I-NP
assayed	assayed	NN	I-NP
in	in	IN	0
vitro	vitro	NN	B-NP
using	using	VBG	0
histone	histone	CD	B-NP
1	1	CD	0
as	as	IN	0
substrate	substrate	NN	0
was	was	VBD	0
suppressed	suppressed	VBN	0
by	by	IN	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
,	,	,	0
but	but	CC	0
partially	partially	RB	0
restored	restored	VBN	0
by	by	IN	0
overexpression	overexpression	NN	B-NP
of	of	IN	0
SKP2	SKP2	CD	B-NP
for	for	IN	0
24	24	CD	0
and	and	CC	0
48	48	CD	0
h	h	NNS	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
5C	5C	NNP	0
,	,	,	0
left	left	VBN	0
panel	panel	NN	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
increase	increase	NN	0
was	was	VBD	0
paralleled	paralleled	VBN	0
by	by	IN	0
a	a	DT	0
decrease	decrease	NN	0
in	in	IN	0
the	the	DT	0
amount	amount	NN	0
of	of	IN	0
p27	p27	CD	B-NP
associated	associated	VBN	0
with	with	IN	0
cyclin	cyclin	JJ	B-NP
E	E	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
5C	5C	NNP	0
,	,	,	0
right	right	JJ	0
panel	panel	NN	0
)	)	-RRB-	0
.	.	.	0
While	While	IN	0
this	this	DT	0
decrease	decrease	NN	0
was	was	VBD	0
maintained	maintained	VBN	0
throughout	throughout	IN	0
the	the	DT	0
course	course	NN	0
of	of	IN	0
the	the	DT	0
experiment	experiment	NN	0
,	,	,	0
CDK2	CDK2	CD	B-NP
activation	activation	NN	I-NP
was	was	VBD	0
attenuated	attenuated	VBN	0
again	again	RB	0
at	at	IN	0
72	72	CD	0
h	h	NN	0
of	of	IN	0
SKP2	SKP2	CD	B-NP
overexpression	overexpression	NNS	0
.	.	.	0
In	In	IN	0
summary	summary	NN	0
,	,	,	0
SKP2	SKP2	NNP	B-NP
overexpression	overexpression	VBD	0
caused	caused	VBN	0
transient	transient	JJ	0
upregulation	upregulation	NN	B-NP
of	of	IN	0
cyclin	cyclin	VBG	0
A	A	DT	0
expression	expression	NN	0
and	and	CC	0
CDK2	CDK2	CD	B-NP
activity	activity	NN	I-NP
,	,	,	0
but	but	CC	0
was	was	VBD	0
inefficient	inefficient	JJ	0
in	in	IN	0
mib-arrested	mib-arrested	NN	B-NP
lncap	lncap	NN	I-NP
cell	cell	NN	I-NP
promoting	promoting	VBG	I-NP
		NN	I-NP
phase	phase	NN	I-NP
entry	entry	NN	I-NP
.	.	.	0
Discussion	Discussion	NNP	0
lncap	lncap	NN	B-NP
cell	cell	NN	I-NP
proliferation	proliferation	NN	I-NP
androgen	androgen	NN	I-NP
control	control	NN	I-NP
We	We	PRP	0
have	have	VBP	0
used	used	VBN	0
the	the	DT	0
cell	cell	NN	B-NP
line	line	NN	I-NP
LNCaP	LNCaP	NN	I-NP
as	as	IN	0
a	a	DT	0
model	model	NN	0
to	to	TO	0
examine	examine	VB	0
the	the	DT	0
role	role	NN	0
of	of	IN	0
SKP2	SKP2	CD	B-NP
in	in	IN	0
p27	p27	CD	B-NP
expression	expression	NN	I-NP
androgen	androgen	JJ	I-NP
control	control	NN	I-NP
and	and	CC	0
cell	cell	NN	0
cycle	cycle	NN	0
progression	progression	NN	0
in	in	IN	0
human	human	JJ	0
prostate	prostate	JJ	B-NP
cancer	cancer	NN	I-NP
cell	cell	NN	I-NP
.	.	.	0
lncap	lncap	NN	B-NP
cell	cell	NN	I-NP
exhibit	exhibit	VBP	0
a	a	DT	0
complex	complex	NN	0
,	,	,	0
but	but	CC	0
characteristic	characteristic	JJ	B-NP
biphasic	biphasic	JJ	I-NP
response	response	NN	I-NP
to	to	TO	0
androgens	androgens	VB	0
:	:	:	0
(	(	-LRB-	0
1	1	LS	0
.	.	.	0
)	)	-RRB-	0
Stimulation	Stimulation	NN	0
of	of	IN	0
proliferation	proliferation	NN	B-NP
at	at	IN	0
low	low	JJ	0
androgen	androgen	JJ	B-NP
level	level	JJ	I-NP
,	,	,	0
and	and	CC	0
(	(	-LRB-	0
2.	2.	NNP	0
)	)	-RRB-	0
inhibition	inhibition	NN	0
of	of	IN	0
proliferation	proliferation	NN	B-NP
at	at	IN	0
higher	higher	JJR	0
levels	levels	NNS	0
such	such	JJ	0
as	as	IN	0
those	those	DT	0
used	used	VBN	0
in	in	IN	0
this	this	DT	0
study	study	NN	0
[	[	-LRB-	0
41	41	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
dichotomy	dichotomy	NN	0
was	was	VBD	0
compared	compared	VBN	0
[	[	-LRB-	0
43	43	CD	0
]	]	-RRB-	0
to	to	TO	0
the	the	DT	0
situation	situation	NN	0
in	in	IN	0
male	male	JJ	0
rodents	rodents	NNS	0
,	,	,	0
where	where	WRB	0
castration	castration	JJ	B-NP
lead	lead	NN	I-NP
to	to	TO	0
atrophy	atrophy	VB	0
of	of	IN	0
the	the	DT	0
prostate	prostate	JJ	B-NP
due	due	JJ	0
to	to	TO	0
apoptosis	apoptosis	VB	0
.	.	.	0
androgen	androgen	NN	B-NP
re-administration	re-administration	NN	I-NP
induces	induces	FW	0
transient	transient	JJ	B-NP
epithelial	epithelial	NN	I-NP
cell	cell	NN	I-NP
proliferation	proliferation	NN	I-NP
,	,	,	0
presumably	presumably	RB	0
mediated	mediated	VBN	0
by	by	IN	0
p27	p27	NNP	B-NP
proteolytic	proteolytic	JJ	I-NP
downregulation	downregulation	NN	I-NP
,	,	,	0
until	until	IN	0
pre-castration	pre-castration	JJ	B-NP
cell	cell	NN	I-NP
number	number	NN	I-NP
have	have	VBP	0
been	been	VBN	0
restored	restored	VBN	0
[	[	-LRB-	0
48	48	CD	0
49	49	CD	0
]	]	-RRB-	0
.	.	.	0
No	No	DT	0
further	further	JJ	0
proliferation	proliferation	NN	B-NP
ensues	ensues	NN	0
beyond	beyond	IN	0
this	this	DT	0
point	point	NN	0
,	,	,	0
at	at	IN	0
which	which	WDT	0
p27	p27	CD	B-NP
level	level	JJ	I-NP
are	are	VBP	0
increased	increased	VBN	0
again	again	RB	0
,	,	,	0
despite	despite	IN	0
the	the	DT	0
androgen	androgen	NN	B-NP
continuous	continuous	JJ	I-NP
presence	presence	NN	I-NP
.	.	.	0
This	This	DT	0
may	may	MD	0
reflect	reflect	VB	0
androgen	androgen	JJ	B-NP
activity	activity	NN	I-NP
in	in	IN	0
restoring	restoring	VBG	0
the	the	DT	0
glandular	glandular	JJ	B-NP
structure	structure	NN	I-NP
by	by	IN	0
promoting	promoting	VBG	0
postmitotic	postmitotic	JJ	B-NP
differentiation	differentiation	NN	I-NP
[	[	-LRB-	0
48	48	CD	0
49	49	CD	0
]	]	-RRB-	0
.	.	.	0
Consistent	Consistent	JJ	0
with	with	IN	0
this	this	DT	0
view	view	NN	0
,	,	,	0
androgen	androgen	JJ	B-NP
administration	administration	NN	I-NP
to	to	TO	0
intact	intact	JJ	0
rats	rats	NNS	0
resulted	resulted	VBD	0
in	in	IN	0
suppression	suppression	NN	0
of	of	IN	0
epithelial	epithelial	JJ	B-NP
cell	cell	NN	I-NP
proliferation	proliferation	NN	I-NP
prostate	prostate	JJ	I-NP
and	and	CC	0
maintenance	maintenance	NN	0
of	of	IN	0
morphological	morphological	JJ	B-NP
gland	gland	JJ	I-NP
integrity	integrity	NN	I-NP
[	[	-LRB-	0
50	50	CD	0
]	]	-RRB-	0
.	.	.	0
Based	Based	VBN	0
on	on	IN	0
these	these	DT	0
findings	findings	NNS	0
,	,	,	0
we	we	PRP	0
propose	propose	VBP	0
that	that	IN	0
the	the	DT	0
effects	effects	NNS	0
of	of	IN	0
high	high	JJ	0
doses	doses	NNS	0
of	of	IN	0
androgen	androgen	NN	B-NP
on	on	IN	0
SKP2	SKP2	NNP	B-NP
and	and	CC	0
p27	p27	CD	B-NP
in	in	IN	0
lncap	lncap	NN	B-NP
cell	cell	NN	I-NP
described	described	VBD	0
here	here	RB	0
reflect	reflect	VB	0
a	a	DT	0
differentiation	differentiation	NN	B-NP
and	and	CC	0
consolidation	consolidation	NN	B-NP
effect	effect	NN	I-NP
in	in	IN	0
vitro	vitro	NN	B-NP
.	.	.	0
If	If	IN	0
this	this	DT	0
is	is	VBZ	0
the	the	DT	0
case	case	NN	0
,	,	,	0
lncap	lncap	NN	B-NP
cell	cell	NN	I-NP
,	,	,	0
despite	despite	IN	0
being	being	VBG	0
highly	highly	RB	0
metastatic	metastatic	JJ	B-NP
lesion	lesion	NN	I-NP
aneuploid	aneuploid	JJ	I-NP
derivative	derivative	JJ	I-NP
of	of	IN	0
an	an	DT	0
advanced	advanced	JJ	0
cancer	cancer	NN	0
[	[	-LRB-	0
39	39	CD	0
]	]	-RRB-	0
,	,	,	0
may	may	MD	0
have	have	VB	0
retained	retained	VBN	0
some	some	DT	0
aspects	aspects	NNS	0
of	of	IN	0
the	the	DT	0
androgen	androgen	JJ	B-NP
control	control	NN	I-NP
normal	normal	JJ	I-NP
biphasic	biphasic	JJ	I-NP
mechanism	mechanism	NN	I-NP
observed	observed	VBD	0
in	in	IN	0
castrated	castrated	JJ	0
rodents	rodents	NNS	0
.	.	.	0
This	This	DT	0
mechanism	mechanism	NN	0
may	may	MD	0
also	also	RB	0
be	be	VB	0
retained	retained	VBN	0
in	in	IN	0
other	other	JJ	0
prostate	prostate	NN	B-NP
cancer	cancer	NN	I-NP
,	,	,	0
thereby	thereby	RB	0
representing	representing	VBG	0
a	a	DT	0
intervention	intervention	NN	B-NP
potential	potential	JJ	I-NP
target	target	NN	I-NP
.	.	.	0
Role	Role	NN	0
of	of	IN	0
SKP2	SKP2	CD	0
in	in	IN	0
androgen	androgen	JJ	0
control	control	NN	0
of	of	IN	0
p27	p27	CD	0
stability	stability	NN	0
Our	Our	PRP$	0
data	data	NNS	0
indicate	indicate	VBP	0
that	that	IN	0
SKP2	SKP2	NNP	0
is	is	VBZ	0
an	an	DT	0
integral	integral	JJ	0
component	component	NN	0
of	of	IN	0
androgen	androgen	JJ	0
control	control	NN	0
in	in	IN	0
LNCaP	LNCaP	JJ	0
cells	cells	NNS	0
,	,	,	0
as	as	IN	0
it	it	PRP	0
is	is	VBZ	0
down-regulated	down-regulated	JJ	0
in	in	IN	0
an	an	DT	0
AR-mediated	AR-mediated	JJ	0
manner	manner	NN	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
2Band	2Band	CD	0
2C	2C	CD	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
contrast	contrast	NN	0
,	,	,	0
all	all	DT	0
other	other	JJ	0
known	known	VBN	0
SCF	SCF	NNP	B-NP
SKP2subunits	SKP2subunits	NNP	0
examined	examined	NN	0
were	were	VBD	0
largely	largely	RB	0
unresponsive	unresponsive	VBN	0
to	to	TO	0
androgen	androgen	VB	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2A	2A	NNP	0
)	)	-RRB-	0
.	.	.	0
Importantly	Importantly	RB	0
,	,	,	0
SKP2	SKP2	CD	B-NP
overexpression	overexpression	NN	0
is	is	VBZ	0
sufficient	sufficient	JJ	0
to	to	TO	0
reverse	reverse	VB	0
androgen-mediated	androgen-mediated	JJ	B-NP
p27	p27	CD	I-NP
accumulation	accumulation	NN	I-NP
and	and	CC	0
induce	induce	VB	0
p27	p27	CD	B-NP
ubiquitylation	ubiquitylation	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
4Band	4Band	CD	0
4D	4D	CD	0
)	)	-RRB-	0
.	.	.	0
Based	Based	VBN	0
on	on	IN	0
the	the	DT	0
F-box	F-box	JJ	B-NP
dependency	dependency	NN	I-NP
of	of	IN	0
these	these	DT	0
processes	processes	NNS	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
4C	4C	NNP	0
)	)	-RRB-	0
,	,	,	0
we	we	PRP	0
conclude	conclude	VBP	0
that	that	IN	0
SKP2	SKP2	NNP	B-NP
directly	directly	RB	0
triggers	triggers	VBZ	0
the	the	DT	0
ubiquitylation	ubiquitylation	NN	B-NP
and	and	CC	0
degradation	degradation	NN	0
of	of	IN	0
p27	p27	CD	B-NP
in	in	IN	0
lncap	lncap	NN	B-NP
cell	cell	NN	I-NP
,	,	,	0
a	a	DT	0
process	process	NN	0
which	which	WDT	0
is	is	VBZ	0
attenuated	attenuated	VBN	0
by	by	IN	0
androgen-mediated	androgen-mediated	JJ	0
SKP2	SKP2	CD	B-NP
downregulation	downregulation	NNS	0
.	.	.	0
This	This	DT	0
interpretation	interpretation	NN	B-NP
is	is	VBZ	0
consistent	consistent	JJ	0
with	with	IN	0
SKP2	SKP2	CD	B-NP
being	being	VBG	0
a	a	DT	0
proximal	proximal	JJ	B-NP
element	element	NN	I-NP
in	in	IN	0
the	the	DT	0
previously	previously	RB	0
identified	identified	VBN	B-NP
androgen-mediated	androgen-mediated	JJ	I-NP
pathway	pathway	NN	I-NP
of	of	IN	0
cell	cell	NN	0
cycle	cycle	NN	0
inhibition	inhibition	NN	0
in	in	IN	0
lncap	lncap	NN	B-NP
cell	cell	NN	I-NP
.	.	.	0
As	As	IN	0
a	a	DT	0
direct	direct	JJ	0
consequence	consequence	NN	0
of	of	IN	0
SKP2	SKP2	CD	B-NP
downregulation	downregulation	NN	0
,	,	,	0
p27	p27	NNP	B-NP
is	is	VBZ	0
upregulated	upregulated	VBN	0
and	and	CC	0
cyclin	cyclin	VBG	0
A	A	DT	0
is	is	VBZ	0
downregulated	downregulated	VBN	0
.	.	.	0
This	This	DT	0
results	results	NNS	0
in	in	IN	0
inhibition	inhibition	NN	0
of	of	IN	0
CDK2	CDK2	CD	B-NP
activity	activity	NN	I-NP
,	,	,	0
accumulation	accumulation	NN	B-NP
of	of	IN	0
hypophosphorylated	hypophosphorylated	CD	0
RB1	RB1	CD	B-NP
,	,	,	0
inactivation	inactivation	NN	B-NP
of	of	IN	0
E2F1	E2F1	NNP	0
[	[	-LRB-	0
45	45	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
cell	cell	NN	0
cycle	cycle	NN	0
arrest	arrest	NN	0
.	.	.	0
While	While	IN	0
it	it	PRP	0
may	may	MD	0
surprise	surprise	VB	0
that	that	IN	0
SKP2	SKP2	CD	B-NP
overexpression	overexpression	NNS	0
alone	alone	RB	0
is	is	VBZ	0
sufficient	sufficient	JJ	0
to	to	TO	0
mediate	mediate	VB	0
p27	p27	CD	B-NP
degradation	degradation	NN	I-NP
in	in	IN	0
lncap	lncap	NN	B-NP
cell	cell	NN	I-NP
,	,	,	0
given	given	VBN	0
the	the	DT	0
known	known	JJ	0
requirement	requirement	NN	0
for	for	IN	0
p27	p27	CD	B-NP
phosphorylation	phosphorylation	NN	I-NP
[	[	-LRB-	0
24	24	CD	0
]	]	-RRB-	0
,	,	,	0
similar	similar	JJ	0
observation	observation	NN	B-NP
were	were	VBD	0
made	made	VBN	0
in	in	IN	0
rat	rat	JJ	B-NP
fibroblast	fibroblast	NN	I-NP
,	,	,	0
human	human	JJ	0
u87	u87	NN	B-NP
cell	cell	NN	I-NP
,	,	,	0
and	and	CC	0
primary	primary	JJ	B-NP
rat	rat	NN	I-NP
hepatocyte	hepatocyte	NN	I-NP
[	[	-LRB-	0
29	29	CD	0
30	30	CD	0
31	31	CD	0
32	32	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
rat	rat	JJ	B-NP
fibroblast	fibroblast	NN	I-NP
,	,	,	0
these	these	DT	0
findings	findings	NNS	0
correlate	correlate	VBN	0
with	with	IN	0
SKP2-induced	SKP2-induced	CD	B-NP
upregulation	upregulation	NN	I-NP
of	of	IN	0
cyclin	cyclin	JJ	0
A	A	NN	0
and	and	CC	0
CDK2	CDK2	CD	B-NP
kinase	kinase	JJ	I-NP
activity	activity	NN	I-NP
[	[	-LRB-	0
29	29	CD	0
32	32	CD	0
]	]	-RRB-	0
,	,	,	0
which	which	WDT	0
could	could	MD	0
further	further	RB	0
augment	augment	VB	0
p27	p27	CD	B-NP
phosphorylation	phosphorylation	NN	I-NP
and	and	CC	0
degradation	degradation	NN	0
,	,	,	0
ultimately	ultimately	RB	0
stimulating	stimulating	VBG	B-NP
cell	cell	NN	I-NP
to	to	TO	0
enter	enter	VB	0
S	S	NNP	B-NP
phase	phase	NN	I-NP
.	.	.	0
Unlike	Unlike	IN	0
in	in	IN	0
rat	rat	JJ	B-NP
fibroblast	fibroblast	NN	I-NP
and	and	CC	0
human	human	JJ	0
u87	u87	NN	B-NP
cell	cell	NN	I-NP
[	[	-LRB-	0
29	29	CD	0
30	30	CD	0
32	32	CD	0
]	]	-RRB-	0
,	,	,	0
SKP2	SKP2	CD	B-NP
overexpression	overexpression	NN	0
is	is	VBZ	0
not	not	RB	0
sufficient	sufficient	JJ	0
to	to	TO	0
override	override	VB	0
androgen-induced	androgen-induced	JJ	B-NP
G1	G1	CD	I-NP
arrest	arrest	NN	I-NP
in	in	IN	0
lncap	lncap	NN	B-NP
cell	cell	NN	I-NP
,	,	,	0
despite	despite	IN	0
a	a	DT	0
profound	profound	JJ	0
effect	effect	NN	0
on	on	IN	0
p27	p27	CD	B-NP
level	level	JJ	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
5	5	CD	0
)	)	-RRB-	0
.	.	.	0
Consistent	Consistent	JJ	0
with	with	IN	0
this	this	DT	0
finding	finding	NN	0
,	,	,	0
ectopic	ectopic	CD	0
SKP2	SKP2	CD	B-NP
expression	expression	NN	0
was	was	VBD	0
not	not	RB	0
sufficient	sufficient	JJ	0
to	to	TO	0
maintain	maintain	VB	0
high	high	JJ	0
cyclin	cyclin	NN	B-NP
A	A	DT	0
levels	levels	NNS	0
,	,	,	0
CDK2	CDK2	CD	B-NP
activation	activation	NN	I-NP
,	,	,	0
and	and	CC	0
RB1	RB1	CD	B-NP
phosphorylation	phosphorylation	NN	I-NP
for	for	IN	0
prolonged	prolonged	JJ	0
periods	periods	NNS	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
5Band	5Band	CD	0
5C	5C	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
transient	transient	JJ	0
character	character	NN	0
of	of	IN	0
these	these	DT	0
responses	responses	NNS	0
may	may	MD	0
explain	explain	VB	0
the	the	DT	0
failure	failure	NN	0
to	to	TO	0
cause	cause	VB	0
efficient	efficient	JJ	0
S	S	NNP	B-NP
phase	phase	NN	I-NP
entry	entry	NN	I-NP
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
,	,	,	0
in	in	IN	0
particular	particular	JJ	0
as	as	IN	0
cyclin	cyclin	NN	B-NP
co-expression	co-expression	JJ	I-NP
was	was	VBD	0
previously	previously	RB	0
shown	shown	VBN	0
to	to	TO	0
synergize	synergize	VB	0
with	with	IN	0
SKP2	SKP2	CD	B-NP
in	in	IN	0
stimulating	stimulating	VBG	B-NP
CDK2	CDK2	CD	I-NP
activity	activity	NN	I-NP
and	and	CC	0
S	S	NNP	B-NP
phase	phase	NN	I-NP
entry	entry	NN	I-NP
[	[	-LRB-	0
30	30	CD	0
31	31	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
cyclin	cyclin	VBG	0
A	A	DT	0
is	is	VBZ	0
frequently	frequently	RB	0
overexpressed	overexpressed	VBN	0
in	in	IN	0
prostate	prostate	JJ	B-NP
cancer	cancer	NN	I-NP
[	[	-LRB-	0
51	51	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
future	future	JJ	0
experiments	experiments	NNS	0
,	,	,	0
it	it	PRP	0
will	will	MD	0
be	be	VB	0
interesting	interesting	JJ	0
to	to	TO	0
determine	determine	VB	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
combined	combined	JJ	0
overexpression	overexpression	NN	B-NP
of	of	IN	0
SKP2	SKP2	NNP	B-NP
and	and	CC	0
cyclin	cyclin	JJ	0
A	A	NN	0
and	and	CC	0
cyclin	cyclin	JJ	B-NP
E	E	NN	I-NP
on	on	IN	0
cell	cell	NN	0
cycle	cycle	NN	0
progression	progression	NN	0
of	of	IN	0
mib-arrested	mib-arrested	NN	B-NP
cell	cell	NN	I-NP
.	.	.	0
Regardless	Regardless	RB	0
of	of	IN	0
the	the	DT	0
outcome	outcome	NN	0
of	of	IN	0
such	such	JJ	0
experiments	experiments	NNS	0
,	,	,	0
our	our	PRP$	0
data	data	NNS	0
firmly	firmly	RB	0
suggest	suggest	VB	0
that	that	IN	0
SKP2	SKP2	NNP	B-NP
is	is	VBZ	0
a	a	DT	0
central	central	JJ	0
mediator	mediator	NN	0
of	of	IN	0
the	the	DT	0
lncap	lncap	NN	B-NP
cell	cell	NN	I-NP
androgen	androgen	JJ	I-NP
response	response	NN	I-NP
mechanism	mechanism	NN	I-NP
.	.	.	0
However	However	RB	0
,	,	,	0
we	we	PRP	0
do	do	VBP	0
not	not	RB	0
believe	believe	VB	0
that	that	IN	0
SKP2	SKP2	NNP	B-NP
is	is	VBZ	0
a	a	DT	0
direct	direct	JJ	0
androgen	androgen	NN	B-NP
receptor	receptor	NN	I-NP
transcriptional	transcriptional	JJ	I-NP
target	target	NN	I-NP
,	,	,	0
as	as	IN	0
the	the	DT	0
kinetics	kinetics	NN	0
of	of	IN	0
its	its	PRP$	0
downregulation	downregulation	NN	B-NP
were	were	VBD	0
rather	rather	RB	0
slow	slow	VB	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2A	2A	NNP	0
)	)	-RRB-	0
,	,	,	0
suggesting	suggesting	VBG	0
several	several	JJ	0
intermediate	intermediate	JJ	0
steps	steps	NNS	0
culminating	culminating	VBG	0
in	in	IN	0
this	this	DT	0
event	event	NN	0
.	.	.	0
Such	Such	PDT	0
a	a	DT	0
mediator	mediator	NN	0
could	could	MD	0
be	be	VB	0
AS3	AS3	CD	B-NP
,	,	,	0
a	a	DT	0
gene	gene	NN	B-NP
induced	induced	NN	I-NP
by	by	IN	0
androgen	androgen	NN	B-NP
growth	growth	NN	I-NP
inhibiting	inhibiting	NN	I-NP
level	level	JJ	I-NP
with	with	IN	0
kinetics	kinetics	NN	0
that	that	IN	0
precede	precede	JJ	0
cell	cell	NN	0
cycle	cycle	NN	0
arrest	arrest	NN	0
[	[	-LRB-	0
52	52	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
androgen-mediated	androgen-mediated	NN	B-NP
cell	cell	NN	I-NP
cycle	cycle	NN	I-NP
arrest	arrest	NN	I-NP
as3	as3	NN	I-NP
overexpression	overexpression	NN	I-NP
mimic	mimic	JJ	I-NP
in	in	FW	0
mcf7	mcf7	NN	B-NP
cell	cell	NN	I-NP
stably	stably	FW	0
expressing	expressing	VBG	B-NP
exogenou	exogenou	NN	I-NP
AR	AR	NNP	I-NP
,	,	,	0
while	while	IN	0
anti-sense	anti-sense	NNP	B-NP
AS3	AS3	NNP	I-NP
confers	confers	VBZ	0
resistance	resistance	NN	0
to	to	TO	0
androgen-induced	androgen-induced	JJ	B-NP
growth	growth	NN	I-NP
arrest	arrest	NN	I-NP
[	[	-LRB-	0
53	53	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
function	function	NN	0
of	of	IN	0
AS3	AS3	NNP	B-NP
is	is	VBZ	0
still	still	RB	0
unknown	unknown	JJ	0
,	,	,	0
but	but	CC	0
the	the	DT	0
encoded	encoded	JJ	0
protein	protein	NN	B-NP
has	has	VBZ	0
features	features	NNS	0
of	of	IN	0
a	a	DT	0
potential	potential	JJ	B-NP
transcription	transcription	JJ	I-NP
factor	factor	NN	I-NP
[	[	-LRB-	0
53	53	CD	0
]	]	-RRB-	0
.	.	.	0
While	While	IN	0
our	our	PRP$	0
study	study	NN	0
suggests	suggests	VBZ	0
that	that	IN	0
SKP2	SKP2	NNP	B-NP
is	is	VBZ	0
an	an	DT	0
important	important	JJ	0
player	player	NN	0
in	in	IN	0
p27	p27	CD	B-NP
regulation	regulation	NN	I-NP
in	in	IN	0
prostate	prostate	JJ	B-NP
cancer	cancer	NN	I-NP
cell	cell	NN	I-NP
,	,	,	0
recent	recent	JJ	0
studies	studies	NNS	0
have	have	VBP	0
also	also	RB	0
implicated	implicated	VBN	0
another	another	DT	0
protein	protein	NN	B-NP
,	,	,	0
CSN5	CSN5	NNP	B-NP
/	/	NNP	0
JAB1	JAB1	NNP	B-NP
,	,	,	0
in	in	IN	0
p27	p27	CD	B-NP
regulation	regulation	NN	I-NP
[	[	-LRB-	0
54	54	CD	0
55	55	CD	0
]	]	-RRB-	0
.	.	.	0
CSN5	CSN5	NNP	B-NP
is	is	VBZ	0
a	a	DT	0
cop9	cop9	NN	B-NP
subunit	subunit	NN	I-NP
/	/	CD	0
signalosoma	signalosoma	NN	B-NP
(	(	-LRB-	0
cop9/signalosome	cop9/signalosome	NN	B-NP
)	)	-RRB-	0
complex	complex	NN	0
[	[	-LRB-	0
56	56	CD	0
57	57	CD	0
58	58	CD	0
59	59	CD	0
]	]	-RRB-	0
,	,	,	0
but	but	CC	0
also	also	RB	0
forms	forms	VBZ	0
distinct	distinct	JJ	0
complexes	complexes	NNS	0
apparently	apparently	RB	0
lacking	lacking	VBG	B-NP
csn	csn	NN	I-NP
subunit	subunit	NN	I-NP
[	[	-LRB-	0
55	55	CD	0
60	60	CD	0
61	61	CD	0
62	62	CD	0
]	]	-RRB-	0
.	.	.	0
Overexpression	Overexpression	NNP	B-NP
of	of	IN	0
CSN5	CSN5	CD	B-NP
in	in	IN	0
NIH3T3	NIH3T3	CD	0
cells	cells	NNS	0
causes	causes	VBZ	0
p27	p27	CD	B-NP
export	export	NN	I-NP
from	from	IN	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
and	and	CC	0
ectopic	ectopic	JJ	B-NP
degradation	degradation	NN	I-NP
[	[	-LRB-	0
54	54	CD	0
]	]	-RRB-	0
.	.	.	0
Notably	Notably	RB	0
,	,	,	0
like	like	IN	0
SKP2	SKP2	NNP	B-NP
[	[	-LRB-	0
33	33	CD	0
36	36	CD	0
37	37	CD	0
38	38	CD	0
]	]	-RRB-	0
,	,	,	0
CSN5	CSN5	NNP	B-NP
was	was	VBD	0
found	found	VBN	0
to	to	TO	0
be	be	VB	0
overexpressed	overexpressed	VBN	0
in	in	IN	0
cancers	cancers	JJ	0
devoid	devoid	NN	0
of	of	IN	0
p27	p27	NNP	B-NP
[	[	-LRB-	0
63	63	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
our	our	PRP$	0
studies	studies	NNS	0
did	did	VBD	0
not	not	RB	0
reveal	reveal	VB	0
any	any	DT	0
effect	effect	NN	0
of	of	IN	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
on	on	IN	0
CSN5	CSN5	CD	B-NP
expression	expression	NN	0
.	.	.	0
Future	Future	JJ	0
studies	studies	NNS	0
aimed	aimed	VBN	0
at	at	IN	0
eliminating	eliminating	VBG	0
CSN5	CSN5	CD	B-NP
activity	activity	NN	0
will	will	MD	0
show	show	VB	0
whether	whether	IN	0
it	it	PRP	0
is	is	VBZ	0
involved	involved	VBN	0
in	in	IN	0
androgen-mediated	androgen-mediated	JJ	B-NP
p27	p27	CD	I-NP
control	control	NN	I-NP
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
a	a	DT	0
recent	recent	JJ	0
report	report	NN	0
p27	p27	CD	B-NP
demonstrated	demonstrated	VBD	I-NP
skp2-independent	skp2-independent	NN	I-NP
proteolysi	proteolysi	NN	I-NP
in	in	IN	0
lymphocytes	lymphocytes	VBG	0
derived	derived	VBN	0
from	from	IN	0
SKP2	SKP2	CD	B-NP
knockout	knockout	CD	0
mice	mice	NNS	0
[	[	-LRB-	0
64	64	CD	0
]	]	-RRB-	0
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
thus	thus	RB	0
possible	possible	JJ	0
that	that	IN	0
p27	p27	CD	B-NP
proteolysi	proteolysi	NN	I-NP
is	is	VBZ	0
subject	subject	JJ	0
to	to	TO	0
tissue-specific	tissue-specific	JJ	B-NP
regulation	regulation	NN	I-NP
.	.	.	0
In	In	IN	0
prostate	prostate	JJ	0
cells	cells	NNS	0
,	,	,	0
however	however	RB	0
,	,	,	0
SKP2	SKP2	NNP	B-NP
seems	seems	VBZ	0
to	to	TO	0
be	be	VB	0
a	a	DT	0
major	major	JJ	0
p27	p27	CD	B-NP
degradation	degradation	NN	I-NP
determinant	determinant	NN	I-NP
,	,	,	0
as	as	IN	0
it	it	PRP	0
is	is	VBZ	0
down-regulated	down-regulated	JJ	0
by	by	IN	0
androgen	androgen	NN	B-NP
and	and	CC	0
its	its	PRP$	0
overexpression	overexpression	NN	B-NP
is	is	VBZ	0
sufficient	sufficient	JJ	0
to	to	TO	0
mediate	mediate	VB	0
p27	p27	CD	B-NP
ubiquitylation	ubiquitylation	NN	I-NP
and	and	CC	0
degradation	degradation	NN	0
.	.	.	0
recent	recent	JJ	B-NP
study	study	NN	I-NP
involving	involving	VBG	0
androgen	androgen	JJ	B-NP
administration	administration	NN	I-NP
to	to	TO	0
castrated	castrated	VB	0
rats	rats	NNS	0
have	have	VBP	0
come	come	VBN	0
to	to	TO	0
similar	similar	JJ	0
conclusions	conclusions	NNS	0
[	[	-LRB-	0
49	49	CD	0
]	]	-RRB-	0
.	.	.	0
Conclusions	Conclusions	VBG	0
Our	Our	PRP$	0
data	data	NNS	0
suggest	suggest	VBP	0
that	that	IN	0
androgen-mediated	androgen-mediated	JJ	0
SKP2	SKP2	CD	B-NP
downregulation	downregulation	NN	0
is	is	VBZ	0
responsible	responsible	JJ	0
for	for	IN	0
decreased	decreased	JJ	0
ubiquitylation	ubiquitylation	NN	B-NP
and	and	CC	0
p27	p27	CD	B-NP
accumulation	accumulation	NN	I-NP
in	in	IN	0
lncap	lncap	NN	B-NP
cell	cell	NN	I-NP
,	,	,	0
an	an	DT	0
effect	effect	NN	0
that	that	WDT	0
is	is	VBZ	0
readily	readily	RB	0
overcome	overcome	VB	0
by	by	IN	0
skp2	skp2	NN	B-NP
overexpression	overexpression	NN	I-NP
.	.	.	0
We	We	PRP	0
propose	propose	VBP	0
that	that	IN	0
frequent	frequent	JJ	0
p27	p27	CD	B-NP
downregulation	downregulation	NN	I-NP
in	in	IN	0
prostate	prostate	JJ	B-NP
cancer	cancer	NN	I-NP
may	may	MD	0
be	be	VB	0
caused	caused	VBN	0
by	by	IN	0
SKP2	SKP2	CD	B-NP
overexpression	overexpression	NNS	0
thus	thus	RB	0
enabling	enabling	VBG	B-NP
escape	escape	NN	I-NP
from	from	IN	0
normal	normal	JJ	B-NP
androgen	androgen	JJ	I-NP
control	control	NN	I-NP
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
our	our	VBG	0
in	in	IN	0
vitro	vitro	JJ	B-NP
study	study	NN	I-NP
validate	validate	VBP	0
the	the	DT	0
SKP2	SKP2	JJ	B-NP
pathway	pathway	NN	0
as	as	IN	0
a	a	DT	0
therapeutic	therapeutic	JJ	B-NP
intervention	intervention	NN	I-NP
potential	potential	JJ	I-NP
target	target	NN	I-NP
in	in	IN	0
cancers	cancers	JJ	0
devoid	devoid	NN	0
of	of	IN	0
p27	p27	CD	B-NP
.	.	.	0
Materials	Materials	NNS	0
and	and	CC	0
methods	methods	NNS	0
Plasmids	Plasmids	NNP	0
and	and	CC	0
reagents	reagents	JJ	0
Human	Human	NNP	0
SKP2	SKP2	NNP	0
and	and	CC	0
p27	p27	NNP	0
cDNAs	cDNAs	NNP	0
were	were	VBD	0
kindly	kindly	RB	0
provided	provided	VBN	0
by	by	IN	0
H.	H.	NNP	0
Zhang	Zhang	NNP	0
(	(	-LRB-	0
Yale	Yale	NNP	0
University	University	NNP	0
)	)	-RRB-	0
and	and	CC	0
P.	P.	NNP	0
Jackson	Jackson	NNP	0
(	(	-LRB-	0
Stanford	Stanford	NNP	0
University	University	NNP	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
genes	genes	NNS	0
were	were	VBD	0
amplified	amplified	VBN	0
by	by	IN	0
PCR	PCR	NNP	B-NP
and	and	CC	0
cloned	cloned	VBN	0
into	into	IN	0
pcDNA3	pcDNA3	CD	B-NP
enabling	enabling	NN	I-NP
in	in	IN	0
vitro	vitro	JJ	B-NP
transcription	transcription	NN	I-NP
.	.	.	0
The	The	DT	0
SKP2	SKP2	NNP	B-NP
mutant	mutant	VBZ	0
lacking	lacking	VBG	0
the	the	DT	0
F-box	F-box	NN	B-NP
was	was	VBD	0
constructed	constructed	VBN	0
using	using	VBG	0
the	the	DT	0
Quickchange	Quickchange	NNP	B-NP
kit	kit	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
Stratagene	Stratagene	NNP	B-NP
.	.	.	0
Probes	Probes	NNS	0
for	for	IN	0
Northern	Northern	JJ	0
blotting	blotting	NN	0
were	were	VBD	0
generated	generated	VBN	0
by	by	IN	0
PCR	PCR	NNP	B-NP
.	.	.	0
The	The	DT	0
GAPDH	GAPDH	NNP	B-NP
probe	probe	NN	I-NP
was	was	VBD	0
generated	generated	VBN	0
by	by	IN	0
reverse	reverse	JJ	B-NP
transcription	transcription	NN	I-NP
and	and	CC	0
PCR	PCR	NNP	B-NP
from	from	IN	0
LNCaP	LNCaP	JJ	B-NP
m	m	JJ	I-NP
RNA	RNA	NNP	I-NP
.	.	.	0
The	The	DT	0
synthetic	synthetic	JJ	B-NP
androgen	androgen	JJ	I-NP
mibolerona	mibolerona	NN	I-NP
(	(	-LRB-	0
7α-17α-dimethyl-19-nortestosterone	7α-17α-dimethyl-19-nortestosterone	NNP	0
)	)	-RRB-	0
was	was	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
perkin	perkin	NNP	B-NP
elmer	elmer	NNP	I-NP
life	life	NN	I-NP
science	science	NN	I-NP
.	.	.	0
The	The	DT	0
antiandrogen	antiandrogen	JJ	B-NP
cyproterone	cyproterone	JJ	I-NP
acetate	acetate	NN	I-NP
was	was	VBD	0
a	a	DT	0
gift	gift	NN	0
from	from	IN	0
C.	C.	NNP	B-NP
Sonnenschein	Sonnenschein	NNP	I-NP
(	(	-LRB-	0
Tufts	Tufts	NNP	0
University	University	NNP	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
reagents	reagents	NN	0
were	were	VBD	0
dissolved	dissolved	VBN	0
in	in	IN	0
absolute	absolute	JJ	0
ethanol	ethanol	NN	B-NP
.	.	.	0
antibody	antibody	NN	B-NP
:	:	:	0
SKP2	SKP2	CD	B-NP
(	(	-LRB-	0
Zymed	Zymed	NNP	B-NP
32-3300	32-3300	NNP	0
,	,	,	0
1	1	CD	0
:	:	:	0
250	250	CD	0
for	for	IN	0
immunoblotting	immunoblotting	CD	B-NP
)	)	-RRB-	0
,	,	,	0
SKP2	SKP2	NNP	B-NP
(	(	-LRB-	0
Santa	Santa	NNP	B-NP
Cruz	Cruz	NNP	I-NP
sc-7164	sc-7164	NNP	I-NP
,	,	,	0
1	1	CD	0
:	:	:	0
500	500	CD	0
for	for	IN	0
immunofluorescence	immunofluorescence	JJ	B-NP
staining	staining	NN	I-NP
)	)	-RRB-	0
,	,	,	0
p27	p27	NNP	B-NP
(	(	-LRB-	0
Transduction	Transduction	NNP	0
Laboratories	Laboratories	NNPS	0
K25030	K25030	NNP	0
,	,	,	0
1	1	CD	0
:	:	:	0
5000	5000	CD	0
for	for	IN	0
immunoblotting	immunoblotting	NN	B-NP
,	,	,	0
1	1	CD	0
:	:	:	0
1000	1000	CD	0
for	for	IN	0
immunofluorescence	immunofluorescence	JJ	B-NP
staining	staining	NN	I-NP
)	)	-RRB-	0
,	,	,	0
cyclin	cyclin	VBG	0
A	A	DT	0
(	(	-LRB-	0
ab-6	ab-6	NN	B-NP
neomarker	neomarker	NN	I-NP
,	,	,	0
MS-1061	MS-1061	NNP	B-NP
,	,	,	0
1	1	CD	0
:	:	:	0
100	100	CD	0
for	for	IN	0
immunoblotting	immunoblotting	CD	B-NP
)	)	-RRB-	0
,	,	,	0
cyclin	cyclin	JJ	B-NP
E	E	NN	I-NP
(	(	-LRB-	0
ab-1	ab-1	NN	B-NP
neomarker	neomarker	NN	I-NP
,	,	,	0
RB-012	RB-012	NNP	B-NP
,	,	,	0
2	2	CD	0
ug	ug	NN	B-NP
per	per	FW	0
immunoprecipitation	immunoprecipitation	NN	B-NP
)	)	-RRB-	0
cyclin	cyclin	JJ	B-NP
E	E	NN	I-NP
(	(	-LRB-	0
ab-2	ab-2	NN	B-NP
neomarker	neomarker	NN	I-NP
,	,	,	0
MS-870	MS-870	NNP	B-NP
,	,	,	0
1	1	CD	0
:	:	:	0
200	200	CD	0
for	for	IN	0
immunoblotting	immunoblotting	CD	B-NP
)	)	-RRB-	0
,	,	,	0
HRT1	HRT1	NNP	B-NP
(	(	-LRB-	0
affinity-purified	affinity-purified	NN	B-NP
rabbit	rabbit	NN	I-NP
polyclonal	polyclonal	NN	I-NP
,	,	,	0
gift	gift	NN	0
from	from	IN	0
R.	R.	NNP	0
Deshaies	Deshaies	NNP	0
,	,	,	0
1	1	CD	0
:	:	:	0
1000	1000	CD	0
for	for	IN	0
immunoblotting	immunoblotting	CD	B-NP
)	)	-RRB-	0
,	,	,	0
cullin	cullin	NNP	B-NP
1	1	NN	I-NP
(	(	-LRB-	0
Zymed	Zymed	NNP	B-NP
71-8700	71-8700	NNP	0
,	,	,	0
1	1	CD	0
:	:	:	0
250	250	CD	0
for	for	IN	0
immunoblotting	immunoblotting	CD	B-NP
)	)	-RRB-	0
,	,	,	0
SKP1	SKP1	NNP	B-NP
(	(	-LRB-	0
transduction	transduction	NN	B-NP
laboratory	laboratory	NN	I-NP
610530	610530	CD	0
,	,	,	0
1	1	CD	0
:	:	:	0
5000	5000	CD	0
for	for	IN	0
immunoblotting	immunoblotting	CD	B-NP
)	)	-RRB-	0
,	,	,	0
JAB1	JAB1	NNP	B-NP
/	/	NNP	0
CSN5	CSN5	NNP	B-NP
(	(	-LRB-	0
GeneTex	GeneTex	NNP	B-NP
MS-Jab11-PX1	MS-Jab11-PX1	NNP	I-NP
,	,	,	0
1	1	CD	0
:	:	:	0
1000	1000	CD	0
for	for	IN	0
immunoblotting	immunoblotting	CD	B-NP
)	)	-RRB-	0
,	,	,	0
RB1	RB1	NNP	B-NP
(	(	-LRB-	0
Pharmingen	Pharmingen	NNP	B-NP
554136	554136	CD	0
,	,	,	0
1	1	CD	0
:	:	:	0
500	500	CD	0
for	for	IN	0
immunoblotting	immunoblotting	CD	B-NP
)	)	-RRB-	0
,	,	,	0
CDK2	CDK2	NNP	B-NP
(	(	-LRB-	0
Santo	Santo	NNP	B-NP
Cruz	Cruz	NNP	I-NP
Biotechnology	Biotechnology	NNP	I-NP
sc-163	sc-163	NNP	I-NP
,	,	,	0
2	2	CD	0
ug	ug	NN	B-NP
per	per	IN	0
immunoprecipitation	immunoprecipitation	NN	B-NP
,	,	,	0
1	1	CD	0
:	:	:	0
500	500	CD	0
for	for	IN	0
immunoblotting	immunoblotting	CD	B-NP
)	)	-RRB-	0
,	,	,	0
Tubulin	Tubulin	NNP	B-NP
(	(	-LRB-	0
Sigma	Sigma	NNP	B-NP
T5168	T5168	NNP	0
,	,	,	0
1	1	CD	0
:	:	:	0
2000	2000	CD	0
for	for	IN	0
immunoblotting	immunoblotting	CD	B-NP
)	)	-RRB-	0
.	.	.	0
tissue	tissue	NN	B-NP
culture	culture	NN	I-NP
lncap-fgc	lncap-fgc	NN	I-NP
cell	cell	NN	I-NP
were	were	VBD	0
obtained	obtained	VBN	0
from	from	IN	0
ATCC	ATCC	NNP	B-NP
(	(	-LRB-	0
order	order	NN	0
number	number	NN	0
CRL-10995	CRL-10995	CD	B-NP
)	)	-RRB-	0
and	and	CC	0
maintained	maintained	VBN	0
in	in	IN	0
RPMI	RPMI	NNP	B-NP
supplemented	supplemented	NN	I-NP
with	with	IN	0
10	10	CD	0
%	%	NN	0
fetal	fetal	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
bovine	bovine	JJ	I-NP
serum	serum	NN	I-NP
as	as	RB	0
described	described	VBN	0
[	[	-LRB-	0
46	46	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
noticed	noticed	VBD	0
that	that	DT	0
lncap	lncap	NN	B-NP
cell	cell	NN	I-NP
at	at	IN	0
low	low	JJ	0
density	density	NNS	0
grow	grow	VBP	0
best	best	RB	0
on	on	IN	0
15	15	CD	0
cm	cm	JJ	B-NP
Falcon	Falcon	NNP	I-NP
3025	3025	CD	0
tissue	tissue	NN	0
culture	culture	NN	0
dishes	dishes	NNS	0
and	and	CC	0
that	that	IN	0
the	the	DT	0
effects	effects	NNS	0
of	of	IN	0
SKP2	SKP2	CD	B-NP
overexpression	overexpression	NNS	0
were	were	VBD	0
most	most	RBS	0
pronounced	pronounced	JJ	0
when	when	WRB	0
cells	cells	NNS	0
were	were	VBD	0
cultured	cultured	VBN	0
on	on	IN	0
these	these	DT	0
dishes	dishes	NNS	0
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
adenoviru	adenoviru	NN	B-NP
For	For	IN	0
production	production	NN	0
of	of	IN	0
adenoviru	adenoviru	NN	B-NP
,	,	,	0
the	the	DT	0
ADEASY	ADEASY	NNP	B-NP
system	system	NN	I-NP
was	was	VBD	0
used	used	VBN	0
(	(	-LRB-	0
generously	generously	RB	0
provided	provided	VBN	0
by	by	IN	0
B.	B.	NNP	B-NP
Vogelstein	Vogelstein	NNP	I-NP
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
complete	complete	JJ	0
SKP2	SKP2	NNP	B-NP
cDNA	cDNA	NNP	0
or	or	CC	0
a	a	DT	0
mutant	mutant	NN	B-NP
lacking	lacking	VBG	0
the	the	DT	0
F-box	F-box	JJ	B-NP
(	(	-LRB-	0
SKP2-ΔF	SKP2-ΔF	NNP	B-NP
)	)	-RRB-	0
were	were	VBD	0
cloned	cloned	VBN	0
into	into	IN	0
a	a	DT	0
modified	modified	JJ	0
pcDNA3	pcDNA3	NN	B-NP
plasmid	plasmid	VBZ	0
providing	providing	VBG	0
an	an	DT	0
N-terminal	N-terminal	JJ	B-NP
Myc	Myc	JJ	I-NP
epitope	epitope	JJ	I-NP
tag	tag	NN	I-NP
and	and	CC	0
the	the	DT	0
human	human	JJ	0
lamin	lamin	JJ	B-NP
B	B	NN	I-NP
leader	leader	NN	I-NP
sequence	sequence	NN	I-NP
.	.	.	0
The	The	DT	0
lamin	lamin	JJ	0
B-SKP2	B-SKP2	CD	B-NP
cassette	cassette	NN	0
was	was	VBD	0
removed	removed	VBN	0
and	and	CC	0
cloned	cloned	VBN	0
into	into	IN	0
the	the	DT	0
pADTRACK1	pADTRACK1	JJ	B-NP
shuttle	shuttle	NN	I-NP
vector	vector	NN	I-NP
.	.	.	0
The	The	DT	0
resulting	resulting	VBG	B-NP
plasmid	plasmid	NN	I-NP
was	was	VBD	0
transformed	transformed	VBN	0
into	into	IN	0
bj-adeasy	bj-adeasy	NN	B-NP
cell	cell	NN	I-NP
by	by	IN	0
electroporation	electroporation	NN	B-NP
.	.	.	0
Adenoviral	Adenoviral	NNP	B-NP
DNA	DNA	NNP	I-NP
generated	generated	VBD	0
by	by	IN	0
recombination	recombination	NN	B-NP
in	in	IN	0
bj-adeasy	bj-adeasy	NN	B-NP
cell	cell	NN	I-NP
was	was	VBD	0
isolated	isolated	VBN	0
.	.	.	0
Recombinant	Recombinant	JJ	B-NP
adenoviral	adenoviral	JJ	I-NP
DNA	DNA	NN	I-NP
was	was	VBD	0
transfected	transfected	VBN	0
into	into	IN	0
293	293	CD	0
cells	cells	NNS	0
using	using	VBG	0
standard	standard	JJ	0
calcium	calcium	NN	B-NP
phosphate	phosphate	NN	I-NP
procedure	procedure	NN	I-NP
.	.	.	0
Virus	Virus	NN	0
was	was	VBD	0
harvested	harvested	VBN	0
from	from	IN	0
cells	cells	NNS	0
and	and	CC	0
amplified	amplified	VBN	0
by	by	IN	0
infection	infection	NN	B-NP
of	of	IN	0
293	293	CD	0
cells	cells	NNS	0
.	.	.	0
Amplified	Amplified	JJ	B-NP
virus	virus	NN	I-NP
was	was	VBD	0
purified	purified	VBN	0
by	by	IN	0
cesium	cesium	NN	B-NP
chloride	chloride	NN	I-NP
gradient	gradient	NN	I-NP
centrifugation	centrifugation	NN	I-NP
and	and	CC	0
tittered	tittered	NN	0
.	.	.	0
An	An	DT	0
approximate	approximate	JJ	0
multiplicity	multiplicity	NN	0
of	of	IN	0
infection	infection	NN	B-NP
of	of	IN	0
100	100	CD	0
was	was	VBD	0
used	used	VBN	0
throughout	throughout	IN	0
.	.	.	0
cell	cell	NN	B-NP
lysate	lysate	NN	I-NP
immunological	immunological	NN	I-NP
technique	technique	NN	I-NP
for	for	IN	0
immunoblotting	immunoblotting	NN	B-NP
were	were	VBD	0
prepared	prepared	VBN	0
by	by	IN	0
scraping	scraping	JJ	0
cells	cells	NNS	0
into	into	IN	0
heated	heated	JJ	0
2	2	CD	0
×	×	CD	0
SDS	SDS	JJ	B-NP
sample	sample	NN	I-NP
buffer	buffer	NN	I-NP
.	.	.	0
Samples	Samples	NNS	0
were	were	VBD	0
boiled	boiled	VBN	0
for	for	IN	0
10	10	CD	0
min	min	NN	B-NP
,	,	,	0
centrifuged	centrifuged	NN	0
,	,	,	0
and	and	CC	0
separated	separated	VBN	0
by	by	IN	0
gel	gel	NN	B-NP
electrophoresi	electrophoresi	NN	I-NP
sd	sd	NN	I-NP
.	.	.	0
Proteins	Proteins	NNS	0
were	were	VBD	0
transferred	transferred	VBN	0
onto	onto	IN	0
Immobilon	Immobilon	NNP	B-NP
P	P	NN	I-NP
membrane	membrane	NN	I-NP
(	(	-LRB-	0
Millipore	Millipore	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
blocked	blocked	VBN	0
in	in	IN	0
5	5	CD	0
%	%	NN	0
nonfat	nonfat	VBZ	0
dry	dry	JJ	0
milk	milk	NN	0
dissolved	dissolved	VBN	0
in	in	IN	0
tris-buffered	tris-buffered	JJ	B-NP
saline	saline	NN	I-NP
/	/	CD	0
0.1	0.1	CD	0
%	%	NN	0
Tween	Tween	NNP	B-NP
and	and	CC	0
probed	probed	NN	0
with	with	IN	0
the	the	DT	0
various	various	JJ	0
antibody	antibody	NN	B-NP
.	.	.	0
immunoprecipitation	immunoprecipitation	NN	B-NP
cell	cell	NN	I-NP
lysate	lysate	NN	I-NP
were	were	VBD	0
prepared	prepared	VBN	0
in	in	IN	0
IP-LB	IP-LB	NNP	B-NP
(	(	-LRB-	0
25	25	CD	0
mm	mm	NN	B-NP
tri	tri	NNP	I-NP
,	,	,	0
pH	pH	JJ	0
7.4	7.4	CD	0
,	,	,	0
150	150	CD	0
mM	mM	JJ	B-NP
NaCl	NaCl	NN	I-NP
,	,	,	0
0.5	0.5	CD	0
%	%	NN	0
Triton	Triton	NNP	B-NP
X100	X100	NNP	I-NP
,	,	,	0
10	10	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	JJ	I-NP
leupeptin	leupeptin	NN	I-NP
,	,	,	0
10	10	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	JJ	I-NP
pepstatin	pepstatin	NN	I-NP
,	,	,	0
1	1	CD	0
mM	mM	JJ	B-NP
PMSF	PMSF	NNP	I-NP
,	,	,	0
17	17	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
aprotinin	aprotinin	CD	I-NP
)	)	-RRB-	0
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
scraped	scraped	VBN	0
into	into	IN	0
IP-LB	IP-LB	JJ	B-NP
and	and	CC	0
incubated	incubated	NN	0
on	on	IN	0
ice	ice	NN	0
for	for	IN	0
30	30	CD	0
min	min	NN	B-NP
.	.	.	0
Cell	Cell	NN	B-NP
lysata	lysata	NN	I-NP
was	was	VBD	0
cleared	cleared	VBN	0
by	by	IN	0
centrifugation	centrifugation	NN	B-NP
and	and	CC	0
the	the	DT	0
supernatant	supernatant	NN	B-NP
was	was	VBD	0
incubated	incubated	VBN	0
with	with	IN	0
various	various	JJ	0
antibody	antibody	NN	B-NP
(	(	-LRB-	0
see	see	VB	0
plasmid	plasmid	NN	B-NP
and	and	CC	0
reagents	reagents	JJ	0
section	section	NN	0
above	above	IN	0
)	)	-RRB-	0
.	.	.	0
immunocomplex	immunocomplex	NN	B-NP
were	were	VBD	0
collected	collected	VBN	0
on	on	IN	0
protein	protein	NN	B-NP
A	A	NN	0
or	or	CC	0
g	g	NN	B-NP
bead	bead	NN	I-NP
,	,	,	0
washed	washed	VBD	0
five	five	CD	0
times	times	NNS	0
in	in	IN	0
IP-LB	IP-LB	JJ	B-NP
for	for	IN	0
5	5	CD	0
minutes	minutes	NNS	0
each	each	DT	0
,	,	,	0
dissolved	dissolved	VBN	0
in	in	IN	0
2	2	CD	0
×	×	CD	0
SDS	SDS	JJ	B-NP
sample	sample	NN	I-NP
buffer	buffer	NN	I-NP
,	,	,	0
and	and	CC	0
separated	separated	VBN	0
by	by	IN	0
gel	gel	NN	B-NP
electrophoresi	electrophoresi	NN	I-NP
sd	sd	NN	I-NP
.	.	.	0
For	For	IN	0
immunofluorescence	immunofluorescence	JJ	B-NP
staining	staining	NN	I-NP
,	,	,	0
lncap	lncap	NN	B-NP
cell	cell	NN	I-NP
were	were	VBD	0
plated	plated	VBN	0
onto	onto	IN	0
poly-lysine	poly-lysine	JJ	B-NP
coated	coated	JJ	0
glass	glass	NN	B-NP
coverslip	coverslip	NN	I-NP
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
fixed	fixed	VBN	B-NP
in	in	IN	0
4	4	CD	0
%	%	NN	0
para-formaldehyde	para-formaldehyde	NN	B-NP
in	in	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
and	and	CC	0
permeabilized	permeabilized	NN	0
by	by	IN	0
washing	washing	VBG	0
in	in	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
/	/	CD	0
0.1	0.1	CD	0
%	%	NN	0
Triton	Triton	NNP	B-NP
X100	X100	NNP	I-NP
.	.	.	0
coverslip	coverslip	NN	B-NP
were	were	VBD	0
blocked	blocked	VBN	0
in	in	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
/	/	CD	0
0.1	0.1	CD	0
%	%	NN	0
Triton	Triton	NNP	B-NP
X100	X100	NNP	I-NP
containing	containing	VBG	0
5	5	CD	0
%	%	NN	0
nonfat	nonfat	VBZ	0
dry	dry	JJ	0
milk	milk	NN	0
for	for	IN	0
45	45	CD	0
min	min	NN	B-NP
.	.	.	0
Incubation	Incubation	NNP	0
with	with	IN	0
primary	primary	JJ	0
and	and	CC	0
secondary	secondary	JJ	B-NP
antibody	antibody	NN	I-NP
was	was	VBD	0
in	in	IN	0
the	the	DT	0
same	same	JJ	0
buffer	buffer	NN	B-NP
for	for	IN	0
45	45	CD	0
min	min	CD	B-NP
each	each	DT	0
.	.	.	0
After	After	IN	0
antibody	antibody	NN	B-NP
incubation	incubation	NN	I-NP
,	,	,	0
coverslip	coverslip	NN	B-NP
were	were	VBD	0
washed	washed	VBN	0
five	five	CD	0
times	times	NNS	0
in	in	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
/	/	CD	0
0.1	0.1	CD	0
%	%	NN	0
Triton	Triton	NNP	B-NP
X100	X100	NNP	I-NP
,	,	,	0
followed	followed	VBN	0
by	by	IN	0
mounting	mounting	VBG	0
on	on	IN	0
microscopy	microscopy	JJ	B-NP
slide	slide	NN	I-NP
.	.	.	0
micrograph	micrograph	NN	B-NP
were	were	VBD	0
taken	taken	VBN	0
with	with	IN	0
a	a	DT	0
Spot	Spot	NNP	0
CCD	CCD	NNP	0
camera	camera	NN	0
mounted	mounted	VBD	0
on	on	IN	0
a	a	DT	0
Nikon	Nikon	NNP	B-NP
E600	E600	NNP	I-NP
epifluorescence	epifluorescence	JJ	I-NP
microscope	microscope	NN	I-NP
.	.	.	0
Brightness	Brightness	NNP	0
and	and	CC	0
contrast	contrast	NN	0
of	of	IN	0
the	the	DT	0
images	images	NNS	0
was	was	VBD	0
adjusted	adjusted	VBN	0
in	in	IN	0
Adobe	Adobe	NNP	B-NP
Photoshop	Photoshop	NNP	I-NP
5.0	5.0	NNP	0
.	.	.	0
total	total	JJ	B-NP
cellular	cellular	JJ	I-NP
rna	rna	NN	I-NP
northern	northern	JJ	I-NP
blotting	blotting	VBD	I-NP
isolation	isolation	NN	I-NP
using	using	VBG	0
a	a	DT	0
urea	urea	JJ	B-NP
/	/	CD	I-NP
LiCl	LiCl	JJ	I-NP
protocol	protocol	NN	I-NP
and	and	CC	0
gel	gel	JJ	B-NP
electrophoresi	electrophoresi	NN	I-NP
was	was	VBD	0
performed	performed	VBN	0
as	as	RB	0
described	described	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
65	65	CD	0
]	]	-RRB-	0
.	.	.	0
Gels	Gels	NNP	0
were	were	VBD	0
transferred	transferred	VBN	0
onto	onto	IN	0
Amersham	Amersham	NNP	B-NP
Hybond	Hybond	NNP	I-NP
N+	N+	NNP	I-NP
nylon	nylon	VBD	0
membranes	membranes	VBN	0
in	in	IN	0
20	20	CD	0
×	×	CD	0
SSC	SSC	NNP	B-NP
and	and	CC	0
prehybridized	prehybridized	NN	0
in	in	IN	0
4	4	CD	0
×	×	CD	0
SSC	SSC	NNP	B-NP
,	,	,	0
1	1	CD	0
×	×	CD	0
Denhardt	Denhardt	NNP	0
's	's	POS	0
solution	solution	NN	B-NP
,	,	,	0
0.5	0.5	CD	0
%	%	NN	0
sd	sd	NN	B-NP
for	for	IN	0
2	2	CD	0
h	h	NN	0
at	at	IN	0
68°C	68°C	CD	0
.	.	.	0
skp2	skp2	NN	B-NP
complementary	complementary	JJ	I-NP
dna	dna	NN	I-NP
fragment	fragment	NN	I-NP
,	,	,	0
p27	p27	NNP	B-NP
,	,	,	0
and	and	CC	0
glyceraldehyde	glyceraldehyde	NN	B-NP
3	3	NN	I-NP
phosphate	phosphate	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
dehydrogenase	dehydrogenase	NN	I-NP
were	were	VBD	0
amplified	amplified	VBN	0
by	by	IN	0
PCR	PCR	NNP	B-NP
and	and	CC	0
radiolabeled	radiolabeled	NN	0
by	by	IN	0
random	random	JJ	0
priming	priming	NN	0
.	.	.	0
Filters	Filters	NNS	0
were	were	VBD	0
hybridized	hybridized	VBN	0
for	for	IN	0
16	16	CD	0
h	h	NN	0
at	at	IN	0
68°C	68°C	NNP	0
followed	followed	VBD	0
by	by	IN	0
washing	washing	VBG	0
in	in	IN	0
2	2	CD	0
×	×	CD	0
SSC	SSC	NN	B-NP
at	at	IN	0
68°C	68°C	CD	0
.	.	.	0
Membranes	Membranes	NNP	0
were	were	VBD	0
exposed	exposed	VBN	0
to	to	TO	0
X-ray	X-ray	NN	B-NP
film	film	NN	I-NP
for	for	IN	0
2	2	CD	0
to	to	TO	0
12	12	CD	0
h	h	NNS	0
and	and	CC	0
scanned	scanned	NN	0
with	with	IN	0
a	a	DT	0
signal	signal	NN	B-NP
quantitation	quantitation	NN	I-NP
phosphoimager	phosphoimager	NN	I-NP
.	.	.	0
H1	H1	FW	0
kinase	kinase	FW	0
assay	assay	FW	0
Histone	Histone	NNP	0
1	1	CD	0
kinase	kinase	JJ	0
assays	assays	NN	0
with	with	IN	0
cyclin	cyclin	JJ	0
E	E	NN	0
or	or	CC	0
CDK2	CDK2	CD	0
immunoprecipitates	immunoprecipitates	NNS	0
were	were	VBD	0
performed	performed	VBN	0
as	as	RB	0
described	described	VBN	0
[	[	-LRB-	0
65	65	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
ubiquitylation	ubiquitylation	JJ	B-NP
assay	assay	NN	I-NP
vitroubiquitylation	vitroubiquitylation	NN	I-NP
assay	assay	NN	I-NP
cell	cell	NN	I-NP
lysate	lysate	NN	I-NP
were	were	VBD	0
prepared	prepared	VBN	0
by	by	IN	0
hypotonic	hypotonic	JJ	B-NP
lysi	lysi	NN	I-NP
on	on	IN	0
ice	ice	NN	0
in	in	IN	0
20	20	CD	0
ph	ph	NN	B-NP
mm	mm	NN	I-NP
hepe	hepe	NN	I-NP
7.5	7.5	CD	0
,	,	,	0
15	15	CD	0
mM	mM	JJ	0
MgCl	MgCl	JJ	B-NP
2	2	CD	0
,	,	,	0
5	5	CD	0
mM	mM	JJ	B-NP
KCl	KCl	NN	I-NP
,	,	,	0
1	1	CD	0
mM	mM	JJ	B-NP
DTT	DTT	NNP	I-NP
,	,	,	0
10	10	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	JJ	I-NP
leupeptin	leupeptin	NN	I-NP
,	,	,	0
10	10	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	JJ	I-NP
pepstatin	pepstatin	NN	I-NP
,	,	,	0
1	1	CD	0
mM	mM	JJ	B-NP
PMSF	PMSF	NNP	I-NP
,	,	,	0
17	17	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	NN	I-NP
aprotinin	aprotinin	VBP	0
as	as	RB	0
described	described	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
30	30	CD	0
]	]	-RRB-	0
.	.	.	0
lysate	lysate	NN	B-NP
were	were	VBD	0
cleared	cleared	VBN	0
by	by	IN	0
centrifugation	centrifugation	NN	B-NP
and	and	CC	0
used	used	VBN	0
without	without	IN	0
prior	prior	JJ	0
freezing	freezing	NN	0
.	.	.	0
Radiolabeled	Radiolabeled	JJ	B-NP
wildtype	wildtype	NN	I-NP
and	and	CC	0
T178A	T178A	CD	0
point	point	NN	0
mutant	mutant	VBD	0
p27	p27	NNP	B-NP
were	were	VBD	0
produced	produced	VBN	0
by	by	IN	0
combined	combined	VBN	0
in	in	IN	0
vitro	vitro	JJ	B-NP
transcription	transcription	NN	I-NP
and	and	CC	0
translation	translation	NN	0
in	in	IN	0
rabbit	rabbit	NN	B-NP
reticulocyte	reticulocyte	NN	I-NP
lysate	lysate	NN	I-NP
containing	containing	FW	0
35S-methionine	35S-methionine	FW	0
.	.	.	0
The	The	DT	0
in	in	IN	0
vitro	vitro	JJ	B-NP
translated	translated	JJ	0
proteins	proteins	NNS	0
were	were	VBD	0
incubated	incubated	CD	0
2	2	CD	0
h	h	NN	0
at	at	IN	0
30°C	30°C	CD	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
1	1	CD	0
mM	mM	JJ	B-NP
ATP	ATP	NN	I-NP
with	with	IN	0
recombinant	recombinant	JJ	0
cyclin	cyclin	JJ	B-NP
E	E	NN	I-NP
/	/	CD	0
cdk2	cdk2	NN	B-NP
complex	complex	JJ	I-NP
produced	produced	VBN	0
from	from	IN	0
baculoviru	baculoviru	NN	B-NP
in	in	IN	0
insect	insect	JJ	0
cells	cells	NNS	0
.	.	.	0
phosphorylated	phosphorylated	JJ	B-NP
protein	protein	NN	I-NP
aliquot	aliquot	NN	I-NP
were	were	VBD	0
added	added	VBN	0
to	to	TO	0
a	a	DT	0
reaction	reaction	NN	0
containing	containing	VBG	0
120	120	CD	0
μg	μg	JJ	B-NP
cell	cell	NN	I-NP
lysate	lysate	NN	I-NP
,	,	,	0
recombinant	recombinant	JJ	0
human	human	JJ	0
E1	E1	NN	0
,	,	,	0
0.25	0.25	CD	0
mg	mg	CD	B-NP
/	/	CD	I-NP
ml	ml	JJ	I-NP
ubiquitin	ubiquitin	NN	I-NP
,	,	,	0
1	1	CD	0
μM	μM	JJ	B-NP
ubiquitin	ubiquitin	JJ	I-NP
aldehyde	aldehyde	NN	I-NP
,	,	,	0
1	1	CD	0
μM	μM	JJ	B-NP
okadaic	okadaic	JJ	I-NP
acid	acid	NN	I-NP
,	,	,	0
20	20	CD	0
μM	μM	JJ	B-NP
MG132	MG132	NN	I-NP
,	,	,	0
and	and	CC	0
ATP	ATP	NNP	B-NP
regenerating	regenerating	JJ	0
system	system	NN	0
(	(	-LRB-	0
20	20	CD	0
mM	mM	JJ	B-NP
ATP	ATP	NNP	I-NP
,	,	,	0
10	10	CD	0
mM	mM	JJ	0
creatine	creatine	JJ	B-NP
phosphate	phosphate	NN	I-NP
,	,	,	0
0.1	0.1	FW	0
μg	μg	NN	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
creatine	creatine	NN	I-NP
kinase	kinase	NN	I-NP
)	)	-RRB-	0
.	.	.	0
After	After	IN	0
90	90	CD	0
min	min	NN	B-NP
,	,	,	0
the	the	DT	0
reactions	reactions	NNS	0
were	were	VBD	0
stopped	stopped	VBN	0
by	by	IN	0
sample	sample	NN	B-NP
buffer	buffer	NN	I-NP
sd	sd	NN	I-NP
addition	addition	NN	I-NP
,	,	,	0
and	and	CC	0
reaction	reaction	NN	B-NP
product	product	NN	I-NP
were	were	VBD	0
separated	separated	VBN	0
by	by	IN	0
gel	gel	NN	B-NP
electrophoresi	electrophoresi	NN	I-NP
sd	sd	NN	I-NP
and	and	CC	0
detected	detected	VBN	0
by	by	IN	0
autoradiography	autoradiography	NN	B-NP
.	.	.	0
abbreviation	abbreviation	NN	B-NP
SCF	SCF	NNP	B-NP
=	=	SYM	0
SKP1	SKP1	NN	B-NP
/	/	FW	0
Cullin	Cullin	NNP	B-NP
/	/	NN	I-NP
F-box	F-box	NN	I-NP
protein	protein	NN	I-NP
complex	complex	JJ	I-NP
UBC	UBC	NN	I-NP
=	=	FW	0
conjugating	conjugating	VBG	B-NP
enzyme	enzyme	NN	I-NP
mib	mib	NN	I-NP
ubiquitin	ubiquitin	NN	I-NP
=	=	FW	0
Mibolerone	Mibolerone	NN	B-NP
(	(	-LRB-	0
7α-17α-dimethyl-19-nortestosterone	7α-17α-dimethyl-19-nortestosterone	NNP	0
)	)	-RRB-	0
SKP2	SKP2	NNP	B-NP
=	=	NNP	0
S	S	NNP	B-NP
phase	phase	NN	I-NP
kinase	kinase	VBZ	0
associated	associated	VBN	B-NP
protein	protein	NN	I-NP
2	2	CD	0
CDK2	CDK2	CD	B-NP
=	=	SYM	0
cyclin-dependent	cyclin-dependent	JJ	B-NP
kinase	kinase	NN	I-NP
2	2	CD	0
Authors	Authors	NNP	0
'	'	POS	0
contribution	contribution	NN	B-NP
All	All	DT	0
experiments	experiments	NNS	0
reported	reported	VBD	0
in	in	IN	0
this	this	DT	0
study	study	NN	0
were	were	VBD	0
performed	performed	VBN	0
by	by	IN	0
L-F	L-F	JJ	B-NP
.	.	.	0
L.	L.	NNP	0
with	with	IN	0
the	the	DT	0
following	following	JJ	0
exceptions	exceptions	NNS	0
:	:	:	0
H.S.	H.S.	NNP	B-NP
prepared	prepared	VBD	0
the	the	DT	0
SKP2-ΔF	SKP2-ΔF	JJ	B-NP
mutant	mutant	NN	I-NP
,	,	,	0
SKP2	SKP2	CD	B-NP
adenoviruses	adenoviruses	NN	0
,	,	,	0
and	and	CC	0
provided	provided	VBD	0
initial	initial	JJ	0
evidence	evidence	NN	0
for	for	IN	0
p27	p27	CD	B-NP
upregulation	upregulation	NN	I-NP
by	by	IN	0
mitochondria	mitochondria	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
isolation	isolation	NN	I-NP
buffer	buffer	NN	I-NP
.	.	.	0
D.A.W.	D.A.W.	NNP	0
performed	performed	VBD	0
the	the	DT	0
experiments	experiments	NNS	0
shown	shown	VBN	0
in	in	IN	0
Fig.	Fig.	CD	0
5Band	5Band	CD	0
5C	5C	CD	0
,	,	,	0
conceived	conceived	VBD	0
the	the	DT	0
study	study	NN	0
,	,	,	0
and	and	CC	0
participated	participated	VBD	0
in	in	IN	0
its	its	PRP$	0
design	design	NN	0
and	and	CC	0
coordination	coordination	NN	B-NP
.	.	.	0
All	All	DT	0
authors	authors	NNS	0
read	read	VBP	0
and	and	CC	0
approved	approved	VBD	0
the	the	DT	0
final	final	JJ	B-NP
manuscript	manuscript	NN	I-NP
.	.	.	0
